FDA event 65690 · Recall Observatory

drug · product 1 of 265

ISOSORBIDE DINITRATE, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781155601.

D-1000-2014

Recall number: D-1000-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 384 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ISOSORBIDE DINITRATE, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD22845_10, EXP: 5/2/2014; CALCITRIOL, Capsule, 0.5 mcg, NDC 63304024001, Pedigree: AD32757_10, EXP: 5/14/2014.

Code information

ISOSORBIDE DINITRATE, Tablet, 10 mg has the following codes: Pedigree: AD25264_1, EXP: 5/3/2014; Pedigree: AD32757_34, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 2 of 265

ISOSORBIDE DINITRATE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781163501.

D-1001-2014

Recall number: D-1001-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ISOSORBIDE DINITRATE, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: CILOSTAZOL, Tablet, 100 mg, NDC 00054004421, Pedigree: W003470, EXP: 6/20/2014; PERPHENAZINE, Tablet, 8 mg, NDC 00630506221, Pedigree: AD54605_1, EXP: 4/30/2014.

Code information

ISOSORBIDE DINITRATE, Tablet, 5 mg has the following codes: Pedigree: W003474, EXP: 6/20/2014; Pedigree: AD56882_1, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 3 of 265

IMIPRAMINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781176401.

D-1002-2014

Recall number: D-1002-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: IMIPRAMINE HCL, Tablet, 25 mg may have potentially been mislabeled as the following drug: FENOFIBRATE, Tablet, 54 mg, NDC 00115551110, Pedigree: AD49448_7, EXP: 5/17/2014.

Code information

IMIPRAMINE HCL, Tablet, 25 mg has the following codes: Pedigree: AD49448_10, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 4 of 265

AMANTADINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781204801.

D-1003-2014

Recall number: D-1003-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 499 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: AMANTADINE HCL, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs: ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W002725, EXP: 6/6/2014; clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: W002998, EXP: 6/11/2014; ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: W003672, EXP: 2/28/2014; NIACIN TR, Capsule, 500 mg, N

Code information

AMANTADINE HCL, Capsule, 100 mg has the following codes: Pedigree: W002726, EXP: 6/6/2014; Pedigree: W002997, EXP: 6/11/2014; Pedigree: W003674, EXP: 6/25/2014; Pedigree: W003323, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 5 of 265

TERAZOSIN HCL, Capsule, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781205301.

D-1004-2014

Recall number: D-1004-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TERAZOSIN HCL, Capsule, 5 mg may have potentially been mislabeled as the following drug: DOXAZOSIN MESYLATE, Tablet, 1 mg, NDC 00093812001, Pedigree: W003912, EXP: 6/28/2014.

Code information

TERAZOSIN HCL, Capsule, 5 mg has the following codes: Pedigree: W003913, EXP: 6/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 6 of 265

MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781206701.

D-1005-2014

Recall number: D-1005-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 80 mg, NDC 00378212277, Pedigree: W003213, EXP: 6/14/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011010, Pedigree: AD65317_1, EXP: 5/24/2014.

Code information

MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes: Pedigree: W003215, EXP: 6/14/2014; Pedigree: AD65457_7, EXP: 5/24/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 7 of 265

TACROLIMUS, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210201.

D-1006-2014

Recall number: D-1006-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TACROLIMUS, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs: CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: W003168, EXP: 6/13/2014; ISOSORBIDE MONONITRATE ER, Tablet, 30 mg, NDC 62175012837, Pedigree: W003350, EXP: 6/18/2014.

Code information

TACROLIMUS, Capsule, 0.5 mg has the following codes: Pedigree: W003169, EXP: 6/13/2014; Pedigree: W003351, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 8 of 265

TACROLIMUS, Capsule, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210301.

D-1007-2014

Recall number: D-1007-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 700 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TACROLIMUS, Capsule, 1 mg may have potentially been mislabeled as one of the following drugs: BISOPROLOL FUMARATE, Tablet, 5 mg, NDC 29300012601, Pedigree: AD34934_7, EXP: 5/10/2014; SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD56917_4, EXP: 5/21/2014; SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD73627_11, EXP: 5/30/2014; ATOMOXE

Code information

TACROLIMUS, Capsule, 1 mg has the following codes: Pedigree: AD37056_1, EXP: 5/10/2014; Pedigree: AD56917_7, EXP: 5/21/2014; Pedigree: AD73627_14, EXP: 5/30/2014; Pedigree: W003704, EXP: 6/26/2014; Pedigree: W002508, EXP: 6/3/2014; Pedigree: W003049, EXP: 6/12/2014; Pedigree: W003352, EXP: 3/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 9 of 265

methylPREDNISolone, Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781502201.

D-1008-2014

Recall number: D-1008-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: methylPREDNISolone, Tablet, 4 mg may have potentially been mislabeled as one of the following drugs: LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00378181101, Pedigree: AD52778_37, EXP: 5/20/2014; NABUMETONE, Tablet, 500 mg, NDC 00185014501, Pedigree: AD46426_4, EXP: 5/15/2014; CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: AD54586_10, EXP: 5/21/2014.

Code information

methylPREDNISolone, Tablet, 4 mg has the following codes: Pedigree: AD52778_43, EXP: 5/20/2014; Pedigree: AD46426_10, EXP: 5/15/2014; Pedigree: AD54587_7, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 10 of 265

LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781518392.

D-1009-2014

Recall number: D-1009-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 360 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 88 mcg may have potentially been mislabeled as one of the following drugs: clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD46265_1, EXP: 5/15/2014; HYDROXYCHLOROQUINE SULFATE, Tablet, 200 mg, NDC 63304029601, Pedigree: AD70629_10, EXP: 5/29/2014; HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 76439030910, Pedigree: W003438, EXP:

Code information

LEVOTHYROXINE SODIUM, Tablet, 88 mcg has the following codes: Pedigree: AD46265_34, EXP: 5/15/2014; Pedigree: AD70629_13, EXP: 5/29/2014; Pedigree: W003439, EXP: 6/20/2014; Pedigree: AD60272_73, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 11 of 265

LEVOTHYROXINE SODIUM, Tablet, 137 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781519192.

D-1010-2014

Recall number: D-1010-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD21846_1, EXP: 5/1/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 137 mcg has the following codes: Pedigree: AD22616_10, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 12 of 265

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781532531.

D-1011-2014

Recall number: D-1011-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD32582_3, EXP: 5/9/2014.

Code information

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes: Pedigree: AD32579_7, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 13 of 265

LOSARTAN POTASSIUM, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781570192.

D-1012-2014

Recall number: D-1012-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 50 mg may have potentially been mislabeled as the following drug: ATORVASTATIN CALCIUM, Tablet, 80 mg, NDC 60505267109, Pedigree: AD21965_4, EXP: 5/1/2014.

Code information

LOSARTAN POTASSIUM, Tablet, 50 mg has the following codes: Pedigree: AD21965_10, EXP: 5/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 14 of 265

AMANTADINE HCL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832011100.

D-1013-2014

Recall number: D-1013-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 2400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: AMANTADINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: AD52993_4, EXP: 5/17/2014; QUEtiapine FUMARATE, Tablet, 25 mg, NDC 65862048901, Pedigree: AD49582_22, EXP: 4/30/2014.

Code information

AMANTADINE HCL, Tablet, 100 mg has the following codes: Pedigree: AD54475_1, EXP: 5/20/2014; Pedigree: AD54475_4, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 15 of 265

chlorproMAZINE HCl, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832030200.

D-1014-2014

Recall number: D-1014-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: chlorproMAZINE HCl, Tablet, 50 mg may have potentially been mislabeled as the following drug: ACAMPROSATE CALCIUM DR, Tablet, 333 mg, NDC 00456333001, Pedigree: AD32973_1, EXP: 5/9/2014.

Code information

chlorproMAZINE HCl, Tablet, 50 mg has the following codes: Pedigree: AD32973_4, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 16 of 265

chlorproMAZINE HCl, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832030300.

D-1015-2014

Recall number: D-1015-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: chlorproMAZINE HCl, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: ACYCLOVIR, Tablet, 800 mg, NDC 00093894701, Pedigree: AD70629_1, EXP: 5/29/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: AD70625_1, EXP: 5/29/2014.

Code information

chlorproMAZINE HCl, Tablet, 100 mg has the following codes: Pedigree: AD70629_4, EXP: 5/29/2014; Pedigree: AD70700_1, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 17 of 265

VITAMIN B COMPLEX W/C, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904026013.

D-1016-2014

Recall number: D-1016-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 780 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VITAMIN B COMPLEX W/C, Tablet, 0 mg may have potentially been mislabeled as one of the following drugs: MULTIVITAMIN/ MULTIMINERAL/ LUTEIN, Capsule, 0 mg, NDC 24208063210, Pedigree: AD21846_40, EXP: 5/2/2014; CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units, NDC 00005550924, Pedigree: AD52993_1, EXP: 5/17/2014; MULTIVITAMIN/ MULTIMINERAL/ LUTEIN, Capsule, 0, ND

Code information

VITAMIN B COMPLEX W/C, Tablet, 0 mg has the following codes: Pedigree: AD21846_43, EXP: 5/1/2014; Pedigree: AD52993_31, EXP: 5/17/2014; Pedigree: AD60240_48, EXP: 5/22/2014; Pedigree: W003321, EXP: 6/19/2014; Pedigree: AD46419_7, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 18 of 265

PYRIDOXINE HCL, Tablet, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052060.

D-1017-2014

Recall number: D-1017-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 403 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 50 mg may have potentially been mislabeled as one of the following drugs: MELATONIN, Tablet, 1 mg, NDC 04746900466, Pedigree: AD21846_17, EXP: 5/1/2014; METHOCARBAMOL, Tablet, 500 mg, NDC 00143129001, Pedigree: AD46312_28, EXP: 5/16/2014; LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00074929690, Pedigree: AD22865_16, EXP: 5/2/2014; RILUZOLE, Tablet,

Code information

PYRIDOXINE HCL, Tablet, 50 mg has the following codes: Pedigree: AD22865_19, EXP: 5/2/2014; Pedigree: AD46312_34, EXP: 5/16/2014; Pedigree: AD22865_22, EXP: 5/2/2014; Pedigree: W003257, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 19 of 265

ASCORBIC ACID, Tablet, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052260.

D-1018-2014

Recall number: D-1018-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 3301 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASCORBIC ACID, Tablet, 250 mg may have potentially been mislabeled as one of the following drugs: PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD30024_1, EXP: 5/9/2014; NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_10, EXP: 9/23/2013; PIMOZIDE, Tablet, 2 mg, NDC 57844018701, Pedigree: AD30140_43, EXP: 5/7/2014; OMEGA-3-ACID ETHYL ESTERS, Capsu

Code information

ASCORBIC ACID, Tablet, 250 mg may have potentially been mislabeled as one of the following drugs: PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD30024_1, EXP: 5/9/2014; NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_10, EXP: 9/23/2013; PIMOZIDE, Tablet, 2 mg, NDC 57844018701, Pedigree: AD30140_43, EXP: 5/7/2014; OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, NDC 00173078302, Pedigree: AD46265_43, EXP: 5/15/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, 0, NDC 00904531360, Pedigree: W003098, EXP: 6/13/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W003718, EXP: 6/26/2014; QUEtiapine FUMARATE, Tablet, 100 mg, NDC 60505313301, Pedigree: W003825, EXP: 6/27/2014; BISMUTH SUBSALICYLATE, CHEW Tablet, 262 mg, NDC 00603023516, Pedigree: AD42592_10, EXP: 5/14/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD73623_4, EXP: 5/30/2014; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292055746, Pedigree: W002698, EXP: 6/5/2014; traZODone HCl, Tablet, 150 mg, NDC 50111044101, Pedigree: AD21858_7, EXP: 5/1/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD30197_31, EXP: 5/9/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: W003026, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 20 of 265

ASCORBIC ACID, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052372.

D-1019-2014

Recall number: D-1019-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 598 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASCORBIC ACID, Tablet, 500 mg may have potentially been mislabeled as the following drug: VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: AD42566_1, EXP: 5/14/2014.

Code information

ASCORBIC ACID, Tablet, 500 mg has the following codes: Pedigree: AD42579_1, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 21 of 265

ASCORBIC ACID, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052380.

D-1020-2014

Recall number: D-1020-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 2018 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASCORBIC ACID, Tablet, 500 mg may have potentially been mislabeled as the following drug: OXcarbazepine, Tablet, 150 mg, NDC 62756018388, Pedigree: AD54562_4, EXP: 5/20/2014.

Code information

ASCORBIC ACID, Tablet, 500 mg has the following codes: Pedigree: AD54576_4, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 22 of 265

ASCORBIC ACID, CHEW Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052660.

D-1021-2014

Recall number: D-1021-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASCORBIC ACID, CHEW Tablet, 500 mg may have potentially been mislabeled as the following drug: PHENOL, LOZENGE, 29 mg, NDC 00068021918, Pedigree: AD60428_4, EXP: 5/22/2014.

Code information

ASCORBIC ACID, CHEW Tablet, 500 mg has the following codes: Pedigree: AD60240_54, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 23 of 265

THIAMINE HCL, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904054460.

D-1022-2014

Recall number: D-1022-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: THIAMINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: SIMVASTATIN, Tablet, 5 mg, NDC 00093715298, Pedigree: AD65323_13, EXP: 5/29/2014; CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units, NDC 00904323392, Pedigree: AD54576_1, EXP: 5/20/2014; BUPRENORPHINE HCL SL, Tablet, 2 mg, NDC 00054017613, Pedigree: AD54478_1, EXP: 5/20/2014; P

Code information

THIAMINE HCL, Tablet, 100 mg has the following codes: Pedigree: AD70639_1, EXP: 5/29/2014; Pedigree: AD54559_1, EXP: 5/20/2014; Pedigree: AD52993_16, EXP: 5/20/2014; Pedigree: W003408, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 24 of 265

NIACIN TR, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904062960.

D-1023-2014

Recall number: D-1023-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN TR, Capsule, 250 mg may have potentially been mislabeled as the following drug: METHYLERGONOVINE MALEATE, Tablet, 0.2 mg, NDC 43386014028, Pedigree: W003477, EXP: 6/20/2014.

Code information

NIACIN TR, Capsule, 250 mg has the following codes: Pedigree: W003478, EXP: 6/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 25 of 265

NIACIN TR, Capsule, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904063160.

D-1024-2014

Recall number: D-1024-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 504 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN TR, Capsule, 500 mg may have potentially been mislabeled as one of the following drugs: PERPHENAZINE, Tablet, 16 mg, NDC 00603506321, Pedigree: AD46265_49, EXP: 5/15/2014; MELATONIN, Tablet, 1 mg, NDC 47469000466, Pedigree: AD60240_14, EXP: 5/22/2014; CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: W002693, EXP: 6/5/2014; GLUCOSAMIN

Code information

NIACIN TR, Capsule, 500 mg has the following codes: Pedigree: AD46257_22, EXP: 5/15/2014; Pedigree: AD60240_17, EXP: 5/22/2014; Pedigree: W002696, EXP: 6/5/2014; Pedigree: AD73521_22, EXP: 5/30/2014; Pedigree: W003318, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 26 of 265

ASPIRIN EC, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201360.

D-1025-2014

Recall number: D-1025-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 499 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASPIRIN EC, Tablet, 325 mg may have potentially been mislabeled as one of the following drugs: MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg, NDC 58914001460, Pedigree: AD30180_10, EXP: 5/9/2014; DILTIAZEM HCL ER, Capsule, 240 mg, NDC 49884083109, Pedigree: AD52375_1, EXP: 5/17/2014; ASPIRIN, Tablet, 325 mg, NDC 00536330501, Pedigree: W003355, EXP: 6/19/2014; ASPIRIN, Tab

Code information

ASPIRIN EC, Tablet, 325 mg has the following codes: Pedigree: AD30180_13, EXP: 5/9/2014; Pedigree: AD52378_1, EXP: 5/17/2014; Pedigree: W003356, EXP: 6/19/2014; Pedigree: W003526, EXP: 6/21/2014; Pedigree: AD39588_1, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 27 of 265

TRI-BUFFERED ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201559.

D-1026-2014

Recall number: D-1026-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TRI-BUFFERED ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as the following drug: ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg, NDC 44183044001, Pedigree: W003596, EXP: 5/31/2014.

Code information

TRI-BUFFERED ASPIRIN, Tablet, 325 mg has the following codes: Pedigree: W003581, EXP: 6/24/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 28 of 265

NIACIN, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227160.

D-1027-2014

Recall number: D-1027-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN, Tablet, 100 mg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: W002660, EXP: 6/5/2014.

Code information

NIACIN, Tablet, 100 mg has the following codes: Pedigree: W002661, EXP: 6/5/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 29 of 265

NIACIN, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227260.

D-1028-2014

Recall number: D-1028-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: NAPROXEN, Tablet, 500 mg, NDC 53746019001, Pedigree: AD54516_1, EXP: 5/20/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: W002920, EXP: 6/10/2014.

Code information

NIACIN, Tablet, 500 mg has the following codes: Pedigree: AD52993_10, EXP: 5/20/2014; Pedigree: W002957, EXP: 6/10/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 30 of 265

SELENIUM, Tablet, 50 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904316260.

D-1029-2014

Recall number: D-1029-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup :SELENIUM, Tablet, 50 mcg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD56917_13, EXP: 5/21/2014.

Code information

SELENIUM, Tablet, 50 mcg has the following codes: Pedigree: AD56939_1, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 31 of 265

ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.

D-765-2014

Recall number: D-765-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 40 mg may be potentially mis-labeled as OLANZAPINE, Tablet, 7.5 mg, NDC 60505311203, Pedigree: AD21790_76, EXP: 5/1/2014; ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46265_19, EXP: 5/15/2014; OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD60272_79, EXP: 5/22/2014; OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD73

Code information

ATOMOXETINE HCL, Capsule, 40 mg has the following codes: Pedigree: AD21790_82, EXP: 5/1/2014; Pedigree: AD46265_52, EXP: 5/15/2014; Pedigree: AD60272_89, EXP: 5/22/2014; Pedigree: AD73525_67, EXP: 5/30/2014; Pedigree: W003014, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 32 of 265

DULoxetine HCl DR, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002323560.

D-766-2014

Recall number: D-766-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 600 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DULoxetine HCl DR, Capsule, 20 mg, may be potentially mis-labeled with one of the following drugs: ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: AD30140_28, EXP: 5/7/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD54587_1, EXP: 5/21/2014; FLUoxetine HCl, Capsule, 10 mg , NDC 16714035103, Pedigree: AD70585_13, EXP: 5/29/2014; CHOLECALCIFEROL

Code information

DULoxetine HCl DR, Capsule, 20 mg has the following codes: Pedigree: AD30140_31, EXP: 5/7/2014; Pedigree: AD54587_4, EXP: 5/21/2014; Pedigree: AD70585_16, EXP: 5/29/2014; Pedigree: W003506, EXP: 6/21/2014; Pedigree: AD60272_61, EXP: 5/22/2014; Pedigree: AD21790_49, EXP: 5/1/2014; Pedigree: W003005, EXP: 6/11/2014; Pedigree: W003486, EXP: 6/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 33 of 265

ATOMOXETINE HCL, Capsule, 18 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002323830.

D-767-2014

Recall number: D-767-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 18 mg, may be potentially mis-labeled as the following drug: LOVASTATIN, Tablet, 20 mg, NDC 00185007201, Pedigree: AD28369_1, EXP: 5/7/2014.

Code information

ATOMOXETINE HCL, Capsule, 18 mg has the following codes: Pedigree: AD30140_16, EXP: 5/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 34 of 265

ATOMOXETINE HCL, Capsule, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002325030.

D-768-2014

Recall number: D-768-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 80 mg may be potentially mis-labeled as one of the following drugs: ATOMOXETINE HCL, Capsule, 18 mg, NDC 00002323830, Pedigree: AD30140_16, EXP: 5/7/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 00904531360, Pedigree: W003706, EXP: 6/25/2014; RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: AD60272_40, EXP: 5/22/2014; PRO

Code information

ATOMOXETINE HCL, Capsule, 80 mg has the following codes: Pedigree: AD30140_19, EXP: 5/7/2014; Pedigree: W003685, EXP: 6/25/2014; Pedigree: AD60272_49, EXP: 5/22/2014; Pedigree: W003003, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 35 of 265

RALOXIFENE HCL, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002416530.

D-769-2014

Recall number: D-769-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: RALOXIFENE HCL, Tablet, 60 mg may be potentially mis-labeled as following drug: ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701; Pedigree: W002656, EXP: 6/4/2014.

Code information

RALOXIFENE HCL, Tablet, 60 mg has the following codes: Pedigree: W002644, EXP: 6/5/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 36 of 265

ENTECAVIR, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00003161112.

D-770-2014

Recall number: D-770-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ENTECAVIR, Tablet, 0.5 mg may be potentially mis-labeled as one of the following drugs: ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD30140_25, EXP: 5/7/2014; aMILoride HCl, Tablet, 5 mg, NDC 64980015101, Pedigree: W003686, EXP: 6/26/2014; ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD60272_49, EXP: 5/22/2014.

Code information

ENTECAVIR, Tablet, 0.5 mg has the following codes: Pedigree: AD30140_28, EXP: 5/7/2014; Pedigree: W003687, EXP: 6/26/2014; Pedigree: AD60272_58. EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 37 of 265

MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00004025901.

D-771-2014

Recall number: D-771-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may be potentially mis-labeled as the following drug: CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52412_11, EXP: 5/17/2014.

Code information

MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes: Pedigree: AD49414_1, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 38 of 265

MYCOPHENOLATE MOFETIL, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00004026001.

D-772-2014

Recall number: D-772-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Tablet, 500 mg may be potentially mis-labeled as the following drug: MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 00004025901, Pedigree: AD49414_1, EXP: 5/17/2014.

Code information

MYCOPHENOLATE MOFETIL, Tablet, 500 mg has the following codes: Pedigree: AD49414_4, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 39 of 265

CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00005550924.

D-773-2014

Recall number: D-773-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units may be potentially mis-labeled as the following drug: REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: AD52387_1, EXP: 5/17/2014.

Code information

CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units has the following codes: Pedigree: AD52993_1, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 40 of 265

sitaGLIPtin PHOSPHATE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00006011231.

D-774-2014

Recall number: D-774-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: sitaGLIPtin PHOSPHATE, Tablet, 50 mg may be potentially mis-labeled as one of the following drugs: LACTOBACILLUS, Tablet, 0 mg, NDC 64980012950, Pedigree: AD62992_1, EXP: 5/23/2014; CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: W002860, EXP: 6/7/2014.

Code information

sitaGLIPtin PHOSPHATE, Tablet, 50 mg has the following codes: Pedigree: AD62829_11, EXP: 5/23/2014; Pedigree: W002824, EXP: 6/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 41 of 265

RALTEGRAVIR, Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00006022761.

D-775-2014

Recall number: D-775-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 183 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: RALTEGRAVIR, Tablet, 400 mg may be potentially mis-labeled as one of the following drugs: HYDROCORTISONE, Tablet, 5 mg, NDC00603389919, Pedigree: AD60272_13, EXP: 5/22/2014; HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: W003679, EXP: 6/25/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: AD21790_16, EXP: 5/1/2014.

Code information

RALTEGRAVIR, Tablet, 400 mg has the following codes: Pedigree: AD60272_19, EXP: 5/22/2014; Pedigree: W003680, EXP: 6/25/2014; Pedigree: AD21790_22, EXP: 5/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 42 of 265

MONTELUKAST SODIUM, CHEW Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00006071131.

D-776-2014

Recall number: D-776-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MONTELUKAST SODIUM, CHEW Tablet, 4 mg may be potentially mislabeled as the following drug: DICYCLOMINE HCL, Tablet, 20 mg, NDC 00591079501, Pedigree: AD76639_4, EXP: 5/31/2014.

Code information

MONTELUKAST SODIUM, CHEW Tablet, 4 mg has the following codes: Pedigree: AD76639_11, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 43 of 265

CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00007337113.

D-777-2014

Recall number: D-777-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 29 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CARVEDILOL PHOSPHATE ER, Capsule, 20 mg may be potentially mislabeled as the following drug: BUMETANIDE, Tablet, 1 mg, NDC 00093423301, Pedigree: W003224, EXP: 6/17/2014.

Code information

CARVEDILOL PHOSPHATE ER, Capsule, 20 mg has the following codes: Pedigree: W003225, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 44 of 265

PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00008060601.

D-778-2014

Recall number: D-778-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD60272_16, EXP: 5/22/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 65162066810, Pedigree: AD73646_13, EXP: 5/30/2014.

Code information

PANTOPRAZOLE SODIUM DR, Tablet, 20 mg has the following codes: Pedigree: AD60272_28, EXP: 5/22/2014; Pedigree: AD73525_19, EXP: 5/30/2014

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 45 of 265

SIROLIMUS, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00008104105.

D-779-2014

Recall number: D-779-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SIROLIMUS, Tablet, 1 mg may be potentially mislabeled as one of the following drugs: PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: AD60272_34, EXP: 5/22/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003325, EXP: 6/18/2014.

Code information

SIROLIMUS, Tablet, 1 mg has the following product codes: Pedigree: AD60272_43, EXP: 5/22/2014; Pedigree: W003329, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 46 of 265

TOLTERODINE TARTRATE ER, Capsule, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00009519001.

D-780-2014

Recall number: D-780-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TOLTERODINE TARTRATE ER, Capsule, 2 mg may be potentially mislabeled as one of the following drugs: RANOLAZINE ER , Tablet, 500 mg, NDC 61958100301, Pedigree: AD62995_7, EXP: 5/29/2014; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe), NDC 00904759160, Pedigree: W002717, EXP: 6/6/2014.

Code information

TOLTERODINE TARTRATE ER, Capsule, 2 mg has the following codes: Pedigree: AD65478_1, EXP: 5/29/2014; Pedigree: W002724, EXP: 6/6/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 47 of 265

TOLTERODINE TARTRATE ER, Capsule, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00009519101.

D-781-2014

Recall number: D-781-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TOLTERODINE TARTRATE ER, Capsule, 4 mg may be potentially mislabeled as one of the following drugs: HYDRALAZINE HCL, Tablet, 25 mg, NDC 50111032701, Pedigree: AD49610_4, EXP: 5/16/2014; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, 0 mg, NDC 51991056601, Pedigree: AD73597_1, EXP: 5/31/2014.

Code information

TOLTERODINE TARTRATE ER, Capsule, 4 mg has the following codes: Pedigree: AD49448_1, EXP: 5/17/2014; Pedigree: AD73686_1, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 48 of 265

DRONEDARONE HCL, Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00024414260.

D-782-2014

Recall number: D-782-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DRONEDARONE HCL, Tablet, 400 mg may be potentially as the following drug: METHYLERGONOVINE MALEATE, Tablet, 0.2 mg, NDC 43386014028, Pedigree: AD52778_40, EXP: 5/20/2014.

Code information

DRONEDARONE HCL, Tablet, 400 mg has the following codes: Pedigree: AD52778_52, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 49 of 265

PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032121201.

D-783-2014

Recall number: D-783-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 400 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units may be potentially mislabeled as one of the following drugs: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003726, EXP: 6/26/2014; LANTHANUM CARBONATE, CHEW Tablet, 500 mg, NDC 54092025290, Pedigree: W002790, EXP: 6/6/2014; CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: W002844, EXP: 6/7/2014; AT

Code information

PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units has the following codes: Pedigree: W003731, EXP: 6/26/2014; Pedigree: W002819, EXP: 6/7/2014; Pedigree: W002849; EXP: 6/7/2014; Pedigree: AD30180_4, EXP: 5/8/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 50 of 265

PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032121207.

D-784-2014

Recall number: D-784-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 12 months

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units may be potentially mislabeled as the following drug: ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: AD70639_4, EXP: 7/28/2013.

Code information

PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units has the following codes: Pedigree: AD70639_7, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 51 of 265

PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032122401.

D-785-2014

Recall number: D-785-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 498 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units may be potentially mislabeled as one of the following drugs: SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD70585_7, EXP: 5/29/2014; THYROID, Tablet, 60 mg, NDC 00456045901, Pedigree: W002848, EXP: 6/7/2014; CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: W003744, EXP: 6/26/2014; amLOD

Code information

PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units has the following codes: Pedigree: AD70585_10, EXP: 5/29/2014 Pedigree: W002850, EXP: 6/7/2014; Pedigree: W003856, EXP: 6/26/2014 Pedigree: AD65457_4, EXP: 5/24/2014; Pedigree: AD70655_1, EXP: 5/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 52 of 265

PROGESTERONE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00032170801.

D-786-2014

Recall number: D-786-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PROGESTERONE, Capsule, 100 mg may be potentially mislabeled as the following drug: LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD46265_40, EXP: 5/15/2014.

Code information

PROGESTERONE, Capsule, 100 mg has the following codes: Pedigree: AD46320_1, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 53 of 265

CALCITRIOL, Capsule, 0.25 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054000725.

D-787-2014

Recall number: D-787-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 400 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCITRIOL, Capsule, 0.25 mcg may be potentially as one of the following drugs: ANAGRELIDE HCL, Capsule, 0.5 mg, NDC 00172524160, Pedigree: AD46414_7, EXP: 5/16/2014; BENAZEPRIL HCL, Tablet, 5 mg, NDC 65162075110, Pedigree: AD52778_7, EXP: 5/20/2014; CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: W003615, EXP: 6/25/2014.

Code information

CALCITRIOL, Capsule, 0.25 mcg has the following codes: Pedigree: AD46414_10, EXP: 5/16/2014; Pedigree: AD52778_13, EXP: 5/20/2014; Pedigree: W003638, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 54 of 265

FLECAINIDE ACETATE, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054001125.

D-788-2014

Recall number: D-788-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FLECAINIDE ACETATE, Tablet, 100 mg may be potentially mislabeled as the following drug: COLESTIPOL HCL MICRONIZED, Tablet, 1 g, NDC 59762045001, Pedigree: AD56847_1, EXP: 5/21/2014.

Code information

FLECAINIDE ACETATE, Tablet, 100 mg has the following codes: Pedigree: AD56847_4, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 55 of 265

LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.

D-789-2014

Recall number: D-789-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) may be potentially mislabled as one of the following drugs: CYCLOBENZAPRINE HCL, Tablet, 5 mg, NDC 00591325601, Pedigree: AD73525_7, EXP: 5/30/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD21846_11, EXP: 5/1/2014.

Code information

LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) has the following codes: Pedigree: AD73525_16, EXP: 5/30/2014; Pedigree: AD21790_25, EXP: 5/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 56 of 265

LITHIUM CARBONATE ER, Tablet, 450 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.

D-790-2014

Recall number: D-790-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1899 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 450 mg may be potentially mislabled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD21790_19, EXP: 5/1/2014; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD46257_28, EXP: 5/15/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W002729, EXP: 6

Code information

LITHIUM CARBONATE ER, Tablet, 450 mg has the following codes: Pedigree: AD21790_28, EXP: 5/1/2014 Pedigree: AD46265_10, EXP: 5/15/2014 Pedigree: W002730, EXP: 6/6/2014 Pedigree: W003681, EXP: 6/25/2014 Pedigree: AD60272_25, EXP: 5/22/2014 Pedigree: AD62796_1, EXP: 5/22/2014 Pedigree: W003327, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 57 of 265

LITHIUM CARBONATE ER, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002125.

D-791-2014

Recall number: D-791-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 2400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 300 mg may be potentially mislabled as the following drug: VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD39588_10, EXP: 5/13/2014.

Code information

LITHIUM CARBONATE ER, Tablet, 300 mg has the following codes: Pedigree: AD39564_1, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 58 of 265

CILOSTAZOL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054004421.

D-792-2014

Recall number: D-792-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may be potentially mislabeled as the following drug: CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003469, EXP: 6/20/2014.

Code information

CILOSTAZOL, Tablet, 100 mg has the following codes: Pedigree: W003470, EXP: 6/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 59 of 265

EXEMESTANE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054008013.

D-793-2014

Recall number: D-793-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: EXEMESTANE, Tablet, 25 mg may be potentially mislabeled as the following drug: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003473, EXP: 6/20/2014.

Code information

EXEMESTANE, Tablet, 25 mg has the following codes: Pedigree: W003471, EXP: 6/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 60 of 265

CALCIUM ACETATE, Capsule, 667 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00054008826.

D-794-2014

Recall number: D-794-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 3600 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCIUM ACETATE, Capsule, 667 mg may be potentially mislabeled as one of the following drugs: ZOLPIDEM TARTRATE, Tablet, 2.5 mg (1/2 of 5 mg), NDC 64679071401, Pedigree: AD28355_1, EXP: 5/8/2014; acetaZOLAMIDE, Tablet, 250 mg, NDC 51672402301, Pedigree: AD62865_1, EXP: 5/23/2014; ZINC GLUCONATE, Tablet, 50 mg, NDC 00904319160, Pedigree: W003028, EXP: 6/12/2014; PROPRANO

Code information

CALCIUM ACETATE, Capsule, 667 mg has the following codes: Pedigree:AD30180_1, EXP: 5/8/2014; Pedigree:AD62865_4, EXP: 5/23/2014; Pedigree:W003045, EXP:6/12/2014; Pedigree: AD52412_11, EXP: 5/17/2014; Pedigree: AD54587_1, EXP: 5/21/2014; Pedigree: AD62986_1, EXP: 5/23/2014; Pedigree: AD73623_1, EXP: 5/30/2014; Pedigree: W003469, EXP: 6/20/2014; Pedigree: AD42592_1, EXP: 5/14/2014; Pedigree: AD52778_10, EXP: 5/20/2014; Pedigree: W003460, EXP: 6/20/2014; Pedigree: AD49463_1, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 61 of 265

ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.

D-795-2014

Recall number: D-795-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 399 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ACARBOSE, Tablet, 25 mg may be potentially mislabeled as one of the following drugs: ZINC GLUCONATE, Tablet, 50 mg, NDC 00904319160, Pedigree: AD60240_57, EXP: 5/22/2014; TOLTERODINE TARTRATE ER, Capsule, 2 mg, NDC 00009519001, Pedigree: W002724, EXP: 6/6/2014; SILDENAFIL CITRATE, Tablet, 25 mg, NDC 00069420030, Pedigree: W003646, EXP: 6/25/2014; SEVELAMER CARBONATE, Tab

Code information

ACARBOSE, Tablet, 25 mg has the following codes: Pedigree: AD60272_1, EXP: 5/22/2014; Pedigree: W002725, EXP: 6/6/2014; Pedigree: W003673, EXP: 6/25/2014; Pedigree: W002996, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 62 of 265

BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.

D-796-2014

Recall number: D-796-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BUPRENORPHINE HCL SL, Tablet, 2 mg may be potentially mislabeled as one of the following drugs: DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD37072_4, EXP: 5/13/2014; MAGNESIUM CHLORIDE DR, Tablet, 64 mg, NDC 00904791152, Pedigree: AD54510_1, EXP: 2/28/2014.

Code information

BUPRENORPHINE HCL SL, Tablet, 2 mg has the following codes: Pedigree: AD39573_1, EXP: 5/13/2014; Pedigree: AD54478_1, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 63 of 265

azaTHIOprine, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054408425.

D-797-2014

Recall number: D-797-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: azaTHIOprine, Tablet, 50 mg may have potentially been mislabeled as the following drug: SELENIUM, Tablet, 50 mcg, NDC 00904316260, Pedigree: AD56939_1, EXP: 5/21/2014.

Code information

azaTHIOprine, Tablet, 50 mg has the following codes: Pedigree: AD56832_1, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 64 of 265

DEXAMETHASONE, Tablet, 1 mg, Rx only, Distributed by Aidapack Service, LLC, NDC 00054418125.

D-798-2014

Recall number: D-798-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DEXAMETHASONE, Tablet, 1 mg may have potentially been mislabeled as the following drug: VENLAFAXINE HCL ER, Capsule, 150 mg, NDC 00093738656, Pedigree: AD30993_20, EXP: 5/9/2014.

Code information

DEXAMETHASONE, Tablet, 1 mg has the following codes: Pedigree: AD37088_1, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 65 of 265

MERCapsuleTOPURINE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054458111.

D-799-2014

Recall number: D-799-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 25 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MERCapsuleTOPURINE, Tablet, 50 mg may have potentially been mislabeled as the following drug: ASCORBIC ACID, Tablet, 500 mg, NDC 00904052380, Pedigree: AD54576_4, EXP: 5/20/2014.

Code information

MERCapsuleTOPURINE, Tablet, 50 mg has the following codes: Pedigree: AD54549_1, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 66 of 265

EFAVIRENZ, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00056047492.

D-800-2014

Recall number: D-800-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: EFAVIRENZ, Capsule, 200 mg may have potentially been mislabeled as the following drug: metFORMIN HCl, Tablet 500 mg, NDC 23155010201, Pedigree: AD46312_25, EXP: 5/16/2014.

Code information

EFAVIRENZ , Capsule, 200 mg has the following codes: Pedigree: AD46312_31, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 67 of 265

EFAVIRENZ, Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00056051030.

D-801-2014

Recall number: D-801-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: EFAVIRENZ, Tablet, 600 mg may have potentially been mislabeled as the following drug: NIACIN ER, Tablet, 500 mg, NDC 00074307490, Pedigree: AD73637_1, EXP: 5/30/2014.

Code information

EFAVIRENZ, Tablet, 600 mg has the following codes: Pedigree: AD73646_16, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 68 of 265

PHENOL, LOZENGE, 29 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00068021918.

D-802-2014

Recall number: D-802-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Lozenges

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PHENOL, LOZENGE, 29 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 20 mg, NDC 00378201777, Pedigree: AD49582_10, EXP: 5/16/2014; VITAMIN B COMPLEX W/C, Tablet, 0 mg, NDC 00904026013, Pedigree: AD60240_48, EXP: 5/22/2014.

Code information

PHENOL, LOZENGE, 29 mg has the following codes: Pedigree: AD49582_13, EXP: 5/16/2014; Pedigree: AD60428_4, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 69 of 265

VARENICLINE, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00069046856.

D-803-2014

Recall number: D-803-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 168 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VARENICLINE, Tablet, 0.5 mg may have potentially been mislabeled as one of the following drugs: LACTOBACILLUS GG, Capsule, 0, NDC 49100036374, Pedigree: W003051, EXP: 6/12/2014; SOTALOL HCL, Tablet, 160 mg, NDC 00093106201, Pedigree: AD22609_10, EXP: 4/30/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: AD62796_4, EXP: 5/22/2014.

Code information

VARENICLINE, Tablet, 0.5 mg has the following codes: Pedigree: W003083, EXP: 6/12/2014; Pedigree: AD22616_1, EXP: 5/2/2014; Pedigree: AD62829_1, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 70 of 265

SILDENAFIL CITRATE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00069420030.

D-804-2014

Recall number: D-804-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SILDENAFIL CITRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug: PHENobarbital/ HYOSCYAMINE/ ATROPINE/ SCOPOLAMINE, Tablet, 16.2 mg/0.1037 mg/0.0194 mg/0.0065 mg, NDC 66213042510, Pedigree: W003640, EXP: 6/25/2014.

Code information

SILDENAFIL CITRATE, Tablet, 25 mg has the following codes: Pedigree: W003646, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 71 of 265

PREGABALIN, Capsule, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071101268.

D-805-2014

Recall number: D-805-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PREGABALIN, Capsule, 25 mg may have potentially been mislabeled as one of the following drugs: CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W003713, EXP: 6/26/2014; glyBURIDE MICRONIZED, Tablet, 3 mg, NDC 00093803501, Pedigree: W003155, EXP: 6/13/2014.

Code information

PREGABALIN, Capsule, 25 mg has the following codes: Pedigree: W003777, EXP: 6/26/2014; Pedigree: W003121, EXP:6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 72 of 265

PREGABALIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071101768.

D-806-2014

Recall number: D-806-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 540 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PREGABALIN, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs: LOSARTAN POTASSIUM, Tablet, 50 mg, NDC 00781570192, Pedigree: AD21965_10, EXP: 5/1/2014; CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: AD30180_25, EXP: 5/9/2014; clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg), NDC 00093083201, Pedigree: AD73518_1, EXP: 5/31/2014; OM

Code information

Labeling: Label Mixup: PREGABALIN, Capsule, 200 mg has the following codes: Pedigree: AD21787_1, EXP: 5/1/2014; Pedigree: AD30024_1, EXP: 5/9/2014; Pedigree: AD73518_4, EXP: 5/31/2014; Pedigree W002759, EXP: 6/6/2014; Pedigree: W003397, EXP: 6/19/2014; Pedigree: W003398, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 73 of 265

PHENYTOIN SODIUM ER, Capsule, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071374066.

D-807-2014

Recall number: D-807-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: Unavailable

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PHENYTOIN SODIUM ER, Capsule, 30 mg may have potentially been mislabeled as the following drug: LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W003327, EXP: 6/19/2014.

Code information

PHENYTOIN SODIUM ER, Capsule, 30 mg has the following codes: Pedigree: W003331, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 74 of 265

NIACIN ER, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074307490.

D-808-2014

Recall number: D-808-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 450 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN ER, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: CHOLECALCIFEROL, Capsule, 50000 units, NDC 53191036201, Pedigree: AD60268_4, EXP: 5/22/2014; METAXALONE, Tablet, 800 mg, NDC 64720032110, Pedigree: W003738, EXP: 6/26/2014; CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: W003716, EXP: 6/26/2014; C

Code information

NIACIN ER, Tablet, 500 mg has the following codes: Pedigree: AD60236_4, EXP: 5/22/2014; Pedigree: W003739, EXP: 6/26/2014; Pedigree: W003740, EXP: 6/26/2014; Pedigree: AD73637_1, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 75 of 265

PARICALCITOL, Capsule, 1 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074431730.

D-809-2014

Recall number: D-809-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PARICALCITOL, Capsule, 1 mcg may have potentially been mislabeled as one of the following drugs: ASCORBIC ACID, Tablet, 500 mg, NDC 60258014101, Pedigree: AD23082_19, EXP: 5/6/2014; CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W002666, EXP: 6/5/2014.

Code information

PARICALCITOL, Capsule, 1 mcg has the following codes: Pedigree: AD23082_22, EXP: 5/6/2014; Pedigree: W002667, EXP: 6/5/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 76 of 265

LEVOTHYROXINE SODIUM, Tablet, 125 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074706890.

D-810-2014

Recall number: D-810-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 125 mcg may have potentially been mislabeled as the following drug: MAGNESIUM CHLORIDE DR, Tablet, 64 mg, NDC 00904791152, Pedigree: AD70615_1, EXP: 2/28/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 125 mcg has the following codes: Pedigree: AD70633_4, EXP: 5/23/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 77 of 265

LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074707090.

D-811-2014

Recall number: D-811-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 60 mg, NDC 55513007430, Pedigree: W003742, EXP: 6/26/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes: Pedigree: W003743, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 78 of 265

LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074929690.

D-812-2014

Recall number: D-812-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug: MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 00536406001, Pedigree: AD22865_13, EXP: 5/2/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes: Pedigree: AD22865_16, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 79 of 265

RILUZOLE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00075770060.

D-813-2014

Recall number: D-813-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: RILUZOLE, Tablet, 50 mg may have potentially been mislabeled as the following drug: LACTOBACILLUS, Tablet, 0 mg, NDC 64980012950, Pedigree: AD62986_10, EXP: 5/23/2014.

Code information

RILUZOLE, Tablet, 50 mg has the following codes: Pedigree: AD62992_11, EXP: 5/23/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 80 of 265

FLUVASTATIN SODIUM, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078017615.

D-814-2014

Recall number: D-814-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FLUVASTATIN SODIUM, Capsule, 20 mg may have potentially been mislabeled as the following drug: VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD73597_1, EXP: 5/31/2014.

Code information

FLUVASTATIN SODIUM, Capsule, 20 mg has the following codes: Pedigree: AD73597_7, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 81 of 265

VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.

D-815-2014

Recall number: D-815-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1440 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VALSARTAN, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: TEMAZEPAM, Capsule, 7.5 mg, NDC 00378311001, Pedigree: AD49418_1, EXP: 5/17/2014; VALSARTAN, Tablet, 320 mg, NDC 00078036034, Pedigree: AD65475_7, EXP: 5/28/2014; ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701, Pedigree: AD67989_10, EXP: 5/28/2014; CHOLECALCIFEROL, Tablet

Code information

VALSARTAN, Tablet, 80 mg has the following codes: Pedigree: AD52372_4, EXP: 5/17/2014; Pedigree: AD65475_10, EXP: 5/28/2014; Pedigree: AD68025_1, EXP: 5/28/2014; Pedigree: AD70585_1, EXP: 5/29/2014; Pedigree: W002768, EXP: 6/10/2014; Pedigree: W003535, EXP: 6/21/2014; Pedigree: AD62995_4, EXP: 5/28/2014; Pedigree: AD73597_1, EXP: 5/31/2014; Pedigree: W002616, EXP: 6/4/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 82 of 265

VALSARTAN, Tablet, 160 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035934.

D-816-2014

Recall number: D-816-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1260 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VALSARTAN, Tablet, 160 mg may have potentially been mislabeled as one of the following drugs: PROGESTERONE, Capsule, 100 mg, NDC 00032170801, Pedigree: AD46320_1, EXP: 5/15/2014; CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg), NDC 00143117101, Pedigree: AD46312_4, EXP: 5/16/2014; MYCOPHENOLATE MOFETIL, Tablet, 500 mg, NDC 00004026001, Pedigree: AD49414_4, EXP: 5/17/2014;

Code information

VALSARTAN, Tablet, 160 mg has the following codes: Pedigree: AD39858_1, EXP: 5/16/2014; Pedigree: AD46312_7, EXP: 5/16/2014; Pedigree: AD49414_7, EXP: 5/17/2014; Pedigree: W002767, EXP: 6/6/2014; Pedigree: W003534, EXP: 6/21/2014; Pedigree: W003639, EXP: 6/25/2014; Pedigree: W002851, EXP: 6/7/2014; Pedigree: AD62995_1, EXP: 5/28/2014; Pedigree: W002964, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 83 of 265

VALSARTAN, Tablet, 320 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078036034.

D-817-2014

Recall number: D-817-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VALSARTAN, Tablet, 320 mg may have potentially been mislabeled as the following drug: CILOSTAZOL, Tablet, 100 mg, NDC 60505252201, Pedigree: AD65475_4, EXP: 5/28/2014.

Code information

VALSARTAN, Tablet, 320 mg has the following codes: Pedigree: AD65475_7, EXP: 5/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 84 of 265

MYCOPHENOLIC ACID DR, Tablet, 180 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078038566.

D-818-2014

Recall number: D-818-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MYCOPHENOLIC ACID DR, Tablet, 180 mg may have potentially been mislabeled as the following drug: METHAZOLAMIDE, Tablet, 50 mg, NDC 00781107101, Pedigree: AD37072_11, EXP: 5/13/2014.

Code information

MYCOPHENOLIC ACID DR, Tablet, 180 mg has the following codes: Pedigree: AD37069_1, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 85 of 265

VALSARTAN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078042315.

D-819-2014

Recall number: D-819-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VALSARTAN, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD52372_4, EXP: 5/17/2014; ZINC SULFATE, Capsule, 50 mg, NDC 00904533260, Pedigree: AD30994_8, EXP: 5/9/2014.

Code information

VALSARTAN, Tablet, 40 mg has the following codes: Pedigree: AD52372_1, EXP: 5/17/2014; Pedigree: AD32579_1, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 86 of 265

carBAMazepine ER, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078051005.

D-820-2014

Recall number: D-820-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: carBAMazepine ER, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: ISOSORBIDE DINITRATE ER, Tablet, 40 mg, NDC 57664060088, Pedigree: AD23082_4, EXP: 5/3/2014; SIROLIMUS, Tablet, 1 mg, NDC 00008104105, Pedigree: W003329, EXP: 6/18/2014.

Code information

carBAMazepine ER, Tablet, 100 mg has the following codes: Pedigree: AD30140_22, EXP: 5/7/2014; Pedigree:W003330, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 87 of 265

DESLORATADINE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00085126401.

D-821-2014

Recall number: D-821-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DESLORATADINE, Tablet, 5 mg may have potentially been mislabeled as the following drug: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD30180_28, EXP: 5/9/2014.

Code information

DESLORATADINE, Tablet, 5 mg has the following codes: Pedigree: AD30993_5, EXP: 2/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 88 of 265

VENLAFAXINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093019901.

D-822-2014

Recall number: D-822-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 25 mg may have potentially been mislabeled as one of the following drugs: sitaGLIPtin PHOSPHATE, Tablet, 50 mg, NDC 00006011231, Pedigree: W002824, EXP: 6/7/2014; LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00378181101, Pedigree: W003847, EXP: 6/27/2014; LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD62796_1, EXP: 5/22/2014.

Code information

VENLAFAXINE HCL, Tablet, 25 mg has the following codes: Pedigree: W002825, EXP: 12/31/2013; Pedigree: W003860, EXP: 6/27/2014; Pedigree: AD62796_4, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 89 of 265

CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093029401.

D-823-2014

Recall number: D-823-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: AD46426_22, EXP: 5/15/2014.

Code information

CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg has the following codes: Pedigree: AD46426_28, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 90 of 265

DILTIAZEM HCL, Tablet, 120 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093032101.

D-824-2014

Recall number: D-824-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DILTIAZEM HCL, Tablet, 120 mg, may have potentially been mislabeled as the following drug: NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: AD329737, EXP: 5/9/2014.

Code information

DILTIAZEM HCL, Tablet, 120 mg, has the following codes: Pedigree: AD30197_1, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 91 of 265

METOPROLOL TARTRATE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093073301.

D-825-2014

Recall number: D-825-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 50 mg may have potentially been mislabeled as one of the following drugs: METOPROLOL TARTRATE, Tablet, 25 mg, NDC 57664050652, Pedigree: W003843, EXP: 6/27/2014; ATORVASTATIN CALCIUM, Tablet, 20 mg, NDC 60505257909, Pedigree: W003846, EXP: 6/27/2014; OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: W003898, EXP: 6/27/2014.

Code information

METOPROLOL TARTRATE, Tablet, 50 mg has the following codes: Pedigree: W003844, EXP: 6/27/2014; Pedigree: W003848, EXP: 6/27/2014; Pedigree: W003900, EXP: 6/27/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 92 of 265

PIROXICAM, Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093075601.

D-826-2014

Recall number: D-826-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PIROXICAM, Capsule, 10 mg may have potentially been mislabeled as the following drug: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD30140_10, EXP: 5/7/2014.

Code information

PIROXICAM, Capsule, 10 mg has the following codes: Pedigree: AD21836_1, EXP: 3/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 93 of 265

NORTRIPTYLINE HCL, Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081001.

D-827-2014

Recall number: D-827-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 10 mg may have potentially been mislabeled as the following drug: VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD70585_1, EXP: 5/29/2014.

Code information

NORTRIPTYLINE HCL, Capsule, 10 mg has the following codes: Pedigree: AD70585_4, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 94 of 265

NORTRIPTYLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081201.

D-828-2014

Recall number: D-828-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the following drugs: ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: AD21811_10, EXP: 5/2/2014; LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 42794001802, Pedigree: AD46414_38, EXP: 5/16/2014.

Code information

NORTRIPTYLINE HCL, Capsule, 50 mg has the following codes: Pedigree: AD21790_70, EXP: 5/1/2014; Pedigree: AD46414_47, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 95 of 265

NORTRIPTYLINE HCL, Capsule, 75 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081301.

D-829-2014

Recall number: D-829-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 75 mg may have potentially been mislabeled as one of the following drugs: guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: AD21790_58, EXP: 5/1/2014; MIRTAZAPINE, Tablet, 7.5 mg, NDC 59762141509, Pedigree: W003693, EXP: 4/30/2014.

Code information

NORTRIPTYLINE HCL, Capsule, 75 mg has the following codes: Pedigree: AD21790_73, EXP: 5/1/2014; Pedigree: W003694, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 96 of 265

clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00093083201.

D-830-2014

Recall number: D-830-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg) may have potentially been mislabeled as the following drug: CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: ADWA00002136, EXP: 5/31/2014.

Code information

clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg) has the following codes: Pedigree: AD73518_1, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 97 of 265

NEFAZODONE HCL, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093102506.

D-831-2014

Recall number: D-831-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NEFAZODONE HCL, Tablet, 200 mg may have potentially been mislabeled as the following drug: NEFAZODONE HCL, Tablet, 150 mg, NDC 00093711306, Pedigree: AD46414_41, EXP: 5/16/2014.

Code information

NEFAZODONE HCL, Tablet, 200 mg has the following codes: Pedigree: AD46414_44, EXP: 5/16/2014

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 98 of 265

SOTALOL HCL, Tablet, 120 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106001.

D-832-2014

Recall number: D-832-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SOTALOL HCL, Tablet, 120 mg may have potentially been mislabeled as the following drug: NEOMYCIN SULFATE, Tablet, 500 mg, NDC 51991073801, Pedigree: AD49448_17, EXP: 5/17/2014.

Code information

SOTALOL HCL, Tablet, 120 mg has the following codes: Pedigree: AD49448_20 EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 99 of 265

SOTALOL HCL, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106101.

D-833-2014

Recall number: D-833-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 202 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SOTALOL HCL, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: DILTIAZEM HCL, Tablet, 120 mg, NDC 00093032101, Pedigree: AD30197_1, EXP: 5/9/2014; PROPRANOLOL HCL ER, Capsule, 60 mg, NDC 00228277811, Pedigree: AD54605_4, EXP: 5/20/2014.

Code information

SOTALOL HCL, Tablet, 80 mg has the following codes: Pedigree: AD30993_17, EXP: 5/9/2014; Pedigree: AD52778_85, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 100 of 265

SOTALOL HCL, Tablet, 160 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106201.

D-834-2014

Recall number: D-834-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SOTALOL HCL, Tablet, 160 mg may have potentially been mislabeled as the following drug: DISULFIRAM, Tablet, 250 mg, NDC 64980017101, Pedigree: AD22609_1, EXP: 5/2/2014.

Code information

SOTALOL HCL, Tablet, 160 mg has the following codes: Pedigree: AD22609_10, EXP: 4/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 101 of 265

PIOGLITAZONE HCL, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093204856.

D-835-2014

Recall number: D-835-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PIOGLITAZONE HCL, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs: DOXYCYCLINE MONOHYDRATE, Capsule, 100 mg, NDC 49884072703, Pedigree: AD52778_25, EXP: 5/20/2014; LOVASTATIN, Tablet, 20 mg, NDC 00185007201, Pedigree: W003263, EXP: 6/17/2014.

Code information

PIOGLITAZONE HCL, Tablet, 15 mg has the following codes: Pedigree: AD52778_70, EXP: 5/21/2014; Pedigree: W003264, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 102 of 265

DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093312901.

D-836-2014

Recall number: D-836-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg may have potentially been mislabeled as the following drug: THYROID, Tablet, 30 mg, NDC 00456045801, Pedigree: AD65323_1, EXP: 5/29/2014.

Code information

DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg has the following codes: Pedigree: AD65323_4, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 103 of 265

BUMETANIDE, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093423201.

D-837-2014

Recall number: D-837-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BUMETANIDE, Tablet, 0.5 mg, Rx only may have potentially been mislabeled as the following drug: ERYTHROMYCIN DR EC, Tablet, 250 mg, NDC 24338012213, Pedigree: AD46426_13, EXP: 5/15/2014.

Code information

BUMETANIDE, Tablet, 0.5 mg, Rx only has the following codes: Pedigree: AD46426_25, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 104 of 265

BUMETANIDE, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093423301.

D-838-2014

Recall number: D-838-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BUMETANIDE, Tablet, 1 mg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: W003218, EXP: 6/17/2014.

Code information

BUMETANIDE, Tablet, 1 mg has the following codes: Pedigree: W003224, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 105 of 265

ESCITALOPRAM, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093585001.

D-839-2014

Recall number: D-839-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ESCITALOPRAM, Tablet, 5 mgmay have potentially been mislabeled as the following drug: SODIUM CHLORIDE, Tablet, 1 gm, NDC 00223176001, Pedigree: W003707, EXP: 6/25/2014.

Code information

ESCITALOPRAM, Tablet, 5 mg has the following codes: Pedigree: W003733, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 106 of 265

NEFAZODONE HCL, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093711306.

D-840-2014

Recall number: D-840-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NEFAZODONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug: LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC 42794001902, Pedigree: AD46414_35, EXP: 5/16/2014.

Code information

NEFAZODONE HCL, Tablet, 150 mg has the following codes: Pedigree: AD46414_41, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 107 of 265

SIMVASTATIN, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715298.

D-841-2014

Recall number: D-841-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SIMVASTATIN, Tablet, 5 mg may have potentially been mislabeled as the following drug: LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 13668011390, Pedigree: AD65323_10, EXP: 5/29/2014.

Code information

SIMVASTATIN, Tablet, 5 mg has the following codes: Pedigree: AD65323_13, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 108 of 265

SIMVASTATIN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715598.

D-842-2014

Recall number: D-842-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SIMVASTATIN, Tablet, 40 mg may have potentially been mislabeled as the following drug: METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 63304057901, Pedigree: AD21790_67, EXP: 5/1/2014.

Code information

SIMVASTATIN, Tablet, 40 mg has the following codes: Pedigree: AD22845_4, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 109 of 265

amLODIPine BESYLATE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093716798.

D-843-2014

Recall number: D-843-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: amLODIPine BESYLATE, Tablet, 5 mg may have potentially been mislabeled as the following drug: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: W002839, EXP: 6/7/2014.

Code information

amLODIPine BESYLATE, Tablet, 5 mg has the following codes: Pedigree: W002840, EXP: 6/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 110 of 265

LOSARTAN POTASSIUM, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093736498.

D-844-2014

Recall number: D-844-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 25 mg may have potentially been mislabeled as the following drug: PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: AD46312_22, EXP: 4/30/2014.

Code information

LOSARTAN POTASSIUM, Tablet, 25 mg has the following codes: Pedigree: AD46312_16, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 111 of 265

LOSARTAN POTASSIUM, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093736598.

D-845-2014

Recall number: D-845-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 50 mg may have potentially been mislabeled as the following drug: MIDODRINE HCL, Tablet, 2.5 mg, NDC 00185004001, Pedigree: W003265, EXP: 6/17/2014.

Code information

LOSARTAN POTASSIUM, Tablet, 50 mg has the following codes: Pedigree: W003268, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 112 of 265

VENLAFAXINE HCL, Tablet, 75 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093738201.

D-846-2014

Recall number: D-846-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 75 mg may have potentially been mislabeled as the following drug: TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: W002508, EXP: 6/3/2014.

Code information

VENLAFAXINE HCL, Tablet, 75 mg has the following codes: Pedigree: W002533, EXP: 2/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 113 of 265

VENLAFAXINE HCL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093738301.

D-847-2014

Recall number: D-847-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 100 mg may have potentially was mislabeled as tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD73525_31, EXP: 5/30/2014; and may have potentially been mislabeled as one of the following drugs: methylPREDNISolone, Tablet, 4 mg, NDC 00603459321, Pedigree: AD32764_11, EXP: 3/31/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree:

Code information

VENLAFAXINE HCL, Tablet, 100 mg has the following codes: Pedigree: AD73525_37, EXP: 5/30/2014; Pedigree: AD42566_1, EXP: 5/14/2014; Pedigree: W002619, EXP: 6/4/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 114 of 265

VENLAFAXINE HCL ER, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093738656.

D-848-2014

Recall number: D-848-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VENLAFAXINE HCL ER, Capsule, 150 mg may have potentially been mislabeled as one of the following drugs: SOTALOL HCL, Tablet, 80 mg, NDC 00093106101, Pedigree: AD30993_17, EXP: 5/9/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: W003075, EXP: 6/12/2014; LANTHANUM CARBONATE, CHEW Tablet, 500 mg, NDC 4092025290, Pedigree: W003410, EXP: 6/19/2014.

Code information

VENLAFAXINE HCL ER, Capsule, 150 mg has the following codes: Pedigree: AD30993_20, EXP: 5/9/2014; Pedigree: W003084, EXP: 6/12/2014; Pedigree: W003414, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 115 of 265

IRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093746556.

D-849-2014

Recall number: D-849-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: IRBESARTAN, Tablet, 150 mg may have potentially been mislabeled as the following drug: BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD32757_7, EXP: 5/13/2014.

Code information

IRBESARTAN, Tablet, 150 mg has the following codes: Pedigree: AD42592_7, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 116 of 265

glyBURIDE MICRONIZED, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093803501.

D-850-2014

Recall number: D-850-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: W003154, EXP: 6/13/2014.

Code information

glyBURIDE MICRONIZED, Tablet, 3 mg has the following codes: Pedigree: W003155, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 117 of 265

FAMCICLOVIR, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093811956.

D-851-2014

Recall number: D-851-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FAMCICLOVIR, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: TOLTERODINE TARTRATE ER, Capsule, 4 mg, NDC 00009519101, Pedigree: AD49448_1, EXP: 5/17/2014; THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree: AD54559_1, EXP: 5/20/2014.

Code information

FAMCICLOVIR, Tablet, 500 mg has the following codes: Pedigree: AD49448_4, EXP 5/17/2014; Pedigree: AD54549_4, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 118 of 265

DOXAZOSIN MESYLATE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00093812001.

D-852-2014

Recall number: D-852-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DOXAZOSIN MESYLATE, Tablet, 1 mg may have potentially been mislabeled as the following drug: PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: W003872, EXP: 6/27/2014.

Code information

DOXAZOSIN MESYLATE, Tablet, 1 mg has the following codes: Pedigree: W003912, EXP: 6/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 119 of 265

glyBURIDE, Tablet, 1.25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834201.

D-853-2014

Recall number: D-853-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: glyBURIDE, Tablet, 1.25 mg may have potentially been mislabeled as one of the following drugs: CYPROHEPTADINE HCL, Tablet, 4 mg, NDC 60258085001, Pedigree: W003676, EXP: 6/25/2014; AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: AD21790_1, EXP: 5/1/2014.

Code information

glyBURIDE, Tablet, 1.25 mg has the following codes: Pedigree: W003677, EXP: 2/28/2014; Pedigree: AD21790_10, EXP: 2/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 120 of 265

glyBURIDE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834301.

D-854-2014

Recall number: D-854-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: glyBURIDE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs: sulfaSALAzine, Tablet, 500 mg, NDC 59762500001, Pedigree: AD46265_13, EXP: 5/15/2014; ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: W003687, EXP: 6/26/2014; RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD21790_22, EXP: 5/1/2014; carBAMazepine ER, Tablet, 100 m

Code information

glyBURIDE, Tablet, 2.5 mg has the following codes: Pedigree: AD46265_22, EXP: 5/15/2014; Pedigree: W003688, EXP: 5/31/2014; Pedigree: AD21790_55, EXP: 5/1/2014; Pedigree: AD30140_34, EXP: 5/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 121 of 265

MEXILETINE HCL, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093873901.

D-855-2014

Recall number: D-855-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MEXILETINE HCL, Capsule, 150 mg may have potentially been mislabeled as the following drug: CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD62865_4, EXP: 5/23/2014.

Code information

MEXILETINE HCL, Capsule, 150 mg has the following codes: Pedigree: AD62865_7, EXP: 5/23/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 122 of 265

MEXILETINE HCL, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093874001.

D-856-2014

Recall number: D-856-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MEXILETINE HCL, Capsule, 200 mg may have potentially been mislabeled as the following drug: ISOSORBIDE DINITRATE, Tablet, 10 mg, NDC 00781155601, Pedigree: AD25264_1, EXP: 5/3/2014.

Code information

MEXILETINE HCL, Capsule, 200 mg has the following codes: Pedigree: AD25264_7, EXP: 5/3/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 123 of 265

ACYCLOVIR, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093894001.

D-857-2014

Recall number: D-857-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 493 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ACYCLOVIR, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD60240_51, EXP: 5/22/2014; METOPROLOL TARTRATE, Tablet, 25 mg, NDC 57664050652, Pedigree: W002841, EXP: 6/7/2014; METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003900, EXP: 6/27/2014; acetaZOLAMIDE

Code information

ACYCLOVIR, Capsule, 200 mg has the following codes: Pedigree: AD60272_4, EXP: 5/22/2014; Pedigree: W002899, EXP: 6/10/2014; Pedigree: W003911, EXP: 6/27/2014; Pedigree: W003483, EXP: 6/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 124 of 265

ACYCLOVIR, Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093894701.

D-858-2014

Recall number: D-858-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ACYCLOVIR, Tablet, 800 mg may have potentially been mislabeled as the following drug: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 64679043304, Pedigree: AD70690_4, EXP: 5/29/2014.

Code information

ACYCLOVIR, Tablet, 800 mg has the following codes: Pedigree: AD70629_1, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 125 of 265

TERBUTALINE SULFATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115261101.

D-859-2014

Recall number: D-859-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TERBUTALINE SULFATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: SOTALOL HCL, Tablet, 80 mg, NDC 00093106101, Pedigree: AD52778_85, EXP: 5/21/2014.

Code information

TERBUTALINE SULFATE, Tablet, 2.5 mg has the following codes: Pedigree: AD52778_88, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 126 of 265

FENOFIBRATE, Tablet, 54 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115551110.

D-860-2014

Recall number: D-860-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug: FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD49448_4, EXP: 5/17/2014.

Code information

FENOFIBRATE, Tablet, 54 mg has the following codes: Pedigree: AD49448_7, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 127 of 265

DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.

D-861-2014

Recall number: D-861-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DIGOXIN, Tablet, 0.125 mg may have potentially been mislabeled as one of the following drugs: MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD21846_34, EXP: 5/1/2014; DESMOPRESSIN ACETATE, Tablet, 0.1 mg, NDC 00591246401, Pedigree: AD46426_16, EXP: 5/15/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 00603548221, Pedigree: AD60264_1, EXP: 5/22/2014; LIOTHYRONINE SODIUM,

Code information

DIGOXIN, Tablet, 0.125 mg has the following codes: Pedigree: AD22609_4, EXP: 4/30/2014; Pedigree: AD46426_22, EXP: 5/15/2014; Pedigree: AD62829_8, EXP: 5/23/2014; Pedigree: W003154, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 128 of 265

NICOTINE POLACRILEX, LOZENGE, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00135051001.

D-862-2014

Recall number: D-862-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1216 Lozenges

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NICOTINE POLACRILEX, LOZENGE, 2 mg may have potentially been mislabeled as one of the following drugs: ESTRADIOL, Tablet, 0.5 mg, NDC 00555089902, Pedigree: AD30993_11, EXP: 5/9/2014; ACAMPROSATE CALCIUM DR, Tablet, 333 mg, NDC 00456333001, Pedigree: W002973, EXP: 6/11/2014; CALCITRIOL, Capsule, 0.5 mcg, NDC 63304024001, Pedigree: W003730, EXP: 6/26/2014; ESZOPICLONE, T

Code information

NICOTINE POLACRILEX, LOZENGE, 2 mg has the following codes: Pedigree: AD32973_7, EXP: 5/9/2014; Pedigree: W002974, EXP: 6/11/2014; Pedigree: W003749, EXP: 6/26/2014; Pedigree: W002766, EXP: 6/6/2014; Pedigree: AD21858_1, EXP: 5/1/2014; Pedigree: AD46333_10, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 129 of 265

CapsuleTOPRIL, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117101.

D-863-2014

Recall number: D-863-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 12.5 mg may have potentially been mislabeled as the following drug:, CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: AD52778_13, EXP: 5/20/2014.

Code information

CapsuleTOPRIL, Tablet, 12.5 mg has the following codes: Pedigree: AD52778_16, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 130 of 265

CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117101.

D-864-2014

Recall number: D-864-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg) may have potentially been mislabeled as the following drug:, LUBIPROSTONE, Capsule, 24 mcg, NDC 64764024060, Pedigree: AD46312_1, EXP: 5/16/2014.

Code information

CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg) has the following codes: Pedigree: AD46312_4, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 131 of 265

CapsuleTOPRIL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117201.

D-865-2014

Recall number: D-865-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 99 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 25 mg may have potentially been mislabeled as the following drug: DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree AD54587_4, EXP: 5/21/2014.

Code information

CapsuleTOPRIL, Tablet, 25 mg has the following codes: Pedigree: AD52778_19, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 132 of 265

METHOCARBAMOL, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143129001.

D-866-2014

Recall number: D-866-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: METHOCARBAMOL, Tablet, 500 mg may have potentially been mislabeled as the following drug: LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 00093736498, Pedigree: AD46312_16, EXP: 5/16/2014.

Code information

METHOCARBAMOL, Tablet, 500 mg has the following codes: Pedigree: AD46312_28, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 133 of 265

DOXYCYCLINE HYCLATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143314250.

D-867-2014

Recall number: D-867-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DOXYCYCLINE HYCLATE, Capsule, 100 mg may have potentially been mislabeled as the following drug: RALOXIFENE HCL, Tablet, 60 mg, NDC 00002416530, Pedigree: W002644, EXP: 6/5/2014.

Code information

DOXYCYCLINE HYCLATE, Capsule, 100 mg has the following codes: Pedigree: W002645, EXP: 6/5/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 134 of 265

REPAGLINIDE, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008281.

D-868-2014

Recall number: D-868-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: REPAGLINIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 40 mg, NDC 00078042315, Pedigree: AD52372_1, EXP: 5/17/2014; GUAIFENESIN, Tablet, 200 mg, NDC 00904515460, Pedigree: W002853, EXP: 6/7/2014; MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: W003923, EXP: 6/28/2014.

Code information

REPAGLINIDE, Tablet, 1 mg has the following codes: Pedigree: AD52387_1, EXP: 5/17/2014; Pedigree: W002855, EXP: 6/7/2014; Pedigree: W003924, EXP: 6/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 135 of 265

REPAGLINIDE, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008481.

D-869-2014

Recall number: D-869-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: REPAGLINIDE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD46419_1, EXP: 5/16/2014; PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121207, Pedigree: AD70639_7, EXP: 5/29/2014; DARUNAVIR, Tablet, 800 mg, NDC 59676056630, Pedigree: W003929, EXP: 7/1/2014.

Code information

REPAGLINIDE, Tablet, 2 mg has the following codes: Pedigree: AD46419_4, EXP: 5/16/2014; Pedigree: AD70639_13, EXP: 5/29/2014; Pedigree: W003925, EXP: 7/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 136 of 265

ANAGRELIDE HCL, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00172524160.

D-870-2014

Recall number: D-870-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ANAGRELIDE HCL, Capsule, 0.5 mg may have potentially been mislabeled as the following drug: ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46414_1, EXP: 5/16/2014.

Code information

ANAGRELIDE HCL, Capsule, 0.5 mg has the following codes: Pedigree: AD46414_7, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 137 of 265

FLUCONAZOLE, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00172541360.

D-871-2014

Recall number: D-871-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FLUCONAZOLE, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD65475_10, EXP: 5/28/2014; FLUCONAZOLE, Tablet, 100 mg, NDC 68462010230, Pedigree: W003064, EXP: 6/12/2014.

Code information

FLUCONAZOLE, Tablet, 200 mg has the following codes: Pedigree: AD65475_16, EXP: 5/28/2014; Pedigree: W003065, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 138 of 265

DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071204.

D-872-2014

Recall number: D-872-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 270 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs: DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD65457_19, EXP: 5/24/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD56924_1, EXP: 5/21/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: W003257, EXP: 6/17/2014.

Code information

DUTASTERIDE, Capsule, 0.5 mg has the following codes: Pedigree: AD65475_1, EXP: 5/28/2014; Pedigree: AD54519_1, EXP: 5/21/2014; Pedigree: W003247, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 139 of 265

DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071215.

D-873-2014

Recall number: D-873-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs: PHENOL, LOZENGE, 29 mg, NDC 00068021918, Pedigree: AD49582_13, EXP: 5/16/2014; REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: AD70639_13, EXP: 5/29/2014; CHOLECALCIFEROL, Capsule, 5000 units, NDC 00904598660, Pedigree: AD52993_22, EXP: 5/20/2014.

Code information

DUTASTERIDE, Capsule, 0.5 mg has the following codes: Pedigree: AD49610_1, EXP: 5/16/2014; Pedigree: AD70633_1, EXP: 5/29/2014; Pedigree: AD52778_4, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 140 of 265

OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00173078302.

D-874-2014

Recall number: D-874-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1439 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg may have potentially been mislabeled as one of the following drugs: SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD39858_4, EXP: 5/15/2014; hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W002735, EXP: 6/6/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: W003229, EXP: 6/17/2014

Code information

OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg has the following codes: Pedigree: AD46265_43, EXP: 5/15/2014; Pedigree: W002736, EXP: 6/6/2014; Pedigree: W003243, EXP: 6/17/2014; Pedigree: W003692, EXP: 6/26/2014; Pedigree: AD32757_40, EXP: 5/14/2014; Pedigree: W003011, EXP: 6/12/2014; Pedigree: W003333, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 141 of 265

ASPIRIN DR EC, Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00182106105.

D-875-2014

Recall number: D-875-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1499 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASPIRIN DR EC, Tablet, 81 mg may have potentially been mislabeled as one of the following drugs: SOTALOL HCL, Tablet, 120 mg, NDC 00093106001, Pedigree: AD49448_20, EXP: 5/17/2014; FOLIC ACID, Tablet, 1 mg, NDC 65162036110, Pedigree: W003097, EXP: 6/13/2014.

Code information

ASPIRIN DR EC, Tablet, 81 mg has the following codes: Pedigree: AD52433_1, EXP: 5/17/2014; Pedigree: W003094, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 142 of 265

SENNOSIDES, Tablet, 8.6 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00182109301.

D-876-2014

Recall number: D-876-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.

Code information

SENNOSIDES, Tablet, 8.6 mg has the following codes: Pedigree: AD62992_14, EXP: 5/23/2014; Pedigree: W002979, EXP: 6/11/2014; Pedigree: W003256, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 143 of 265

MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.

D-877-2014

Recall number: D-877-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.

Code information

MIDODRINE HCL, Tablet, 2.5 mg has the following codes: Pedigree: W003265, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 144 of 265

FOSINOPRIL SODIUM, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004109.

D-878-2014

Recall number: D-878-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FOSINOPRIL SODIUM, Tablet, 10 mg may have potentially been mislabeled as the following drug: MERCapsuleTOPURINE, Tablet, 50 mg, NDC 00054458111, Pedigree: AD54549_1, EXP: 5/20/2014.

Code information

FOSINOPRIL SODIUM, Tablet, 10 mg has the following codes: Pedigree: AD54549_7, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 145 of 265

LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.

D-879-2014

Recall number: D-879-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LOVASTATIN, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: AD28349_1, EXP: 2/28/2014; FLUVASTATIN SODIUM, Capsule, 20 mg, NDC 00078017615, Pedigree: AD73597_7, EXP: 5/31/2014; DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: W003247, EXP: 6/17/2014.

Code information

LOVASTATIN, Tablet, 20 mg has the following codes: Pedigree: AD28369_1, EXP: 5/7/2014; Pedigree: AD73597_10, EXP: 5/31/2014; Pedigree: W003263, EXP: 6/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 146 of 265

NABUMETONE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185014501.

D-880-2014

Recall number: D-880-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NABUMETONE, Tablet, 500 mg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD46429_1, EXP: 5/15/2014.

Code information

NABUMETONE, Tablet, 500 mg has the following codes: Pedigree: AD46426_4, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 147 of 265

CILOSTAZOL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185022360.

D-881-2014

Recall number: D-881-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 63 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may have potentially been mislabeled as the following drug: TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, NDC 00591042401, Pedigree: W002900, EXP: 6/10/2014.

Code information

CILOSTAZOL, Tablet, 100 mg has the following codes: Pedigree: W002931, EXP: 6/10/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 148 of 265

CANDESARTAN CILEXETIL, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00186001631.

D-882-2014

Recall number: D-882-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CANDESARTAN CILEXETIL, Tablet, 16 mg may have potentially been mislabeled as the following drug: IRBESARTAN, Tablet, 150 mg, NDC 65862063830, Pedigree: W003649, EXP: 6/25/2014.

Code information

CANDESARTAN CILEXETIL, Tablet, 16 mg has the following codes: Pedigree: W003611, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 149 of 265

SODIUM CHLORIDE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00223176001.

D-883-2014

Recall number: D-883-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 7891 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: BISACODYL EC, Tablet, 5 mg, NDC 00904792760, Pedigree: AD34931_1, EXP: 5/9/2014; DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD70633_1, EXP: 5/29/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002509, EXP: 6/3/2014; SODIUM CHLORIDE, Tabl

Code information

SODIUM CHLORIDE, Tablet, 1 mg has the following codes: Pedigree: AD39560_1, EXP: 5/13/2014; Pedigree: AD70636_1, EXP: 5/29/2014; Pedigree: AD73662_1, EXP: 6/3/2014; Pedigree: W002611, EXP: 6/4/2014; Pedigree: W003792, EXP: 6/27/2014; Pedigree: AD22845_10, EXP: 5/2/2014; Pedigree: W003115, EXP: 6/13/2014; Pedigree: W003707, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 150 of 265

GABAPENTIN, Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228263611.

D-884-2014

Recall number: D-884-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: GABAPENTIN, Tablet, 600 mg may have potentially been mislabeled as the following drug: ARIPiprazole, Tablet, 15 mg, NDC 59148000913, Pedigree: AD21965_1, EXP: 5/1/2014.

Code information

GABAPENTIN, Tablet, 600 mg has the following codes: Pedigree: AD21965_7, EXP: 5/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 151 of 265

PROPRANOLOL HCL ER, Capsule, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228277811.

D-885-2014

Recall number: D-885-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PROPRANOLOL HCL ER, Capsule, 60 mg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD52778_82, EXP: 5/21/2014.

Code information

PROPRANOLOL HCL ER, Capsule, 60 mg has the following codes: Pedigree: AD54605_4, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 152 of 265

HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228282011.

D-886-2014

Recall number: D-886-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg may have potentially been mislabeled as one of the following drugs: hydrALAZINE HCl, Tablet, 100 mg, NDC 23155000401, Pedigree: AD73652_4, EXP: 5/29/2014; CLINDAMYCIN HCL, Capsule, 300 mg, NDC 00591312001, Pedigree: AD67989_1, EXP: 5/28/2014.

Code information

HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg has the following codes: Pedigree: AD73652_7, EXP: 5/29/2014 Pedigree: AD67989_13, EXP: 5/28/2014

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 153 of 265

ROSUVASTATIN CALCIUM, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00310075590.

D-887-2014

Recall number: D-887-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ROSUVASTATIN CALCIUM, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: IBUPROFEN, Tablet, 400 mg, NDC 67877029401, Pedigree: W002577, EXP: 6/3/2014; ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD21846_49, EXP: 5/1/2014.

Code information

ROSUVASTATIN CALCIUM, Tablet, 5 mg has the following codes: Pedigree: W002567, EXP: 6/3/2014; Pedigree: AD21811_10, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 154 of 265

METOPROLOL TARTRATE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378001801.

D-888-2014

Recall number: D-888-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug: DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD76675_1, EXP: 6/3/2014.

Code information

METOPROLOL TARTRATE, Tablet, 25 mg has the following codes: Pedigree: W002535, EXP: 6/3/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 155 of 265

CHLORTHALIDONE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378021301.

D-889-2014

Recall number: D-889-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CHLORTHALIDONE, Tablet, 50 mg may have potentially been mislabeled as the following drug: SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301, Pedigree: W002979, EXP: 6/11/2014.

Code information

CHLORTHALIDONE, Tablet, 50 mg has the following codes: Pedigree: W002988, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 156 of 265

CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00378022201.

D-890-2014

Recall number: D-890-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg) may have potentially been mislabeled as the following drug: PROPRANOLOL HCL, Tablet, 5 mg (1/2 of 10 mg), NDC 23155011001, Pedigree: AD73525_25, EXP: 5/30/2014.

Code information

CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes: Pedigree: AD73525_43, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 157 of 265

ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378041501.

D-891-2014

Recall number: D-891-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg may have potentially been mislabeled as the following drug: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD65475_25, EXP: 5/28/2014. TRI-BUFFERED ASPIRIN, Tablet, 325 mg, NDC 00904201559, Pedigree: W003581, EXP: 6/24/2014.

Code information

ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg has the following codes: Pedigree: AD65475_13, EXP: 5/28/2014; Pedigree: W003597, EXP: 6/24/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 158 of 265

THIORIDAZINE HCL, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378061601.

D-892-2014

Recall number: D-892-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: THIORIDAZINE HCL, Tablet, 50 mg may have potentially been mislabeled as the following drug: guanFACINE HCl, Tablet, 1 mg, NDC 00591044401, Pedigree: AD73525_13, EXP: 4/30/2014.

Code information

THIORIDAZINE HCL, Tablet, 50 mg has the following codes: Pedigree: AD73525_28, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 159 of 265

tiZANidine HCl, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378072219.

D-893-2014

Recall number: D-893-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 150 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: tiZANidine HCl, Tablet, 2 mg may have potentially been mislabeled as the following drug: NIACIN TR, Tablet, 500 mg, NDC 00904434260, Pedigree: W002969, EXP: 6/11/2014.

Code information

tiZANidine HCl, Tablet, 2 mg has the following codes: Pedigree: W002975, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 160 of 265

THIOTHIXENE, Capsule, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378100101.

D-894-2014

Recall number: D-894-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: THIOTHIXENE, Capsule, 1 mg may have potentially been mislabeled as the following drug: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD46257_1, EXP: 5/15/2014.

Code information

THIOTHIXENE, Capsule, 1 mg has the following codes: Pedigree: AD54549_22, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 161 of 265

guanFACINE HC, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378116001.

D-895-2014

Recall number: D-895-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: guanFACINE HC, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: AD46265_22, EXP: 5/15/2014; FOSINOPRIL SODIUM, Tablet, 10 mg, NDC 60505251002, Pedigree: AD46414_19, EXP: 5/16/2014; chlorproMAZINE HCl, Tablet, 100 mg, NDC 00832030300, Pedigree: AD70629_4, EXP: 5/29/2014; guanFACINE HCl,

Code information

guanFACINE HC, Tablet, 1 mg has the following codes: Pedigree: AD46265_25, EXP: 5/15/2014; Pedigree: AD46414_22, EXP: 5/16/2014; Pedigree: AD70629_7, EXP: 5/29/2014; Pedigree: W003007, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 162 of 265

TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378135201.

D-896-2014

Recall number: D-896-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg may have potentially been mislabeled as the following drug: CAFFEINE, Tablet, 100 mg (1/2 of 200 mg), NDC 24385060173, Pedigree: AD30028_31, EXP: 5/8/2014.

Code information

TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mghas the following codes: Pedigree: AD28333_4, EXP: 5/6/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 163 of 265

LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378180701.

D-897-2014

Recall number: D-897-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 600 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 88 mcg may have potentially been mislabeled as one of the following drugs: NEBIVOLOL HCL, Tablet, 5 mg, NDC 00456140530, Pedigree: AD73611_7, EXP: 5/30/2014; MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: W003022, EXP: 6/12/2014; ISOSORBIDE DINITRATE, Tablet, 5 mg, NDC 00781163501, Pedigree: W003474, EXP: 6/20/2014; HYDROCORTISONE, Tabl

Code information

LEVOTHYROXINE SODIUM, Tablet, 88 mcg has the following codes: Pedigree: AD73652_10, EXP: 5/30/2014; Pedigree: W003047, EXP: 6/12/2014; Pedigree: W003476, EXP: 6/20/2014; Pedigree: W002967, EXP: 6/11/2014; Pedigree: AD42584_1, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 164 of 265

LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181101.

D-898-2014

Recall number: D-898-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 499 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as one of the following drugs: ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn), NDC 00904533260, Pedigree: AD57624_1, EXP: 5/9/2014; hydrALAZINE HCl, Tablet, 50 mg, NDC 50111032801, Pedigree: AD52778_28, EXP: 5/20/2014; CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W003828, EXP: 6/

Code information

LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes: Pedigree: AD60211_1, EXP: 5/21/2014; Pedigree: AD52778_37, EXP: 5/20/2014; Pedigree: W003847, EXP: 6/27/2014; Pedigree: AD30197_13, EXP: 5/9/2014; Pedigree: AD49423_7, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 165 of 265

LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181701

D-899-2014

Recall number: D-899-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug: PRAMIPEXOLE DI-HCL, Tablet, 1 mg, NDC 16714058701, Pedigree: W003150, EXP: 6/13/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes: Pedigree: W003151, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 166 of 265

ATORVASTATIN CALCIUM, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201577.

D-900-2014

Recall number: D-900-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 990 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: AD30180_4, EXP: 5/8/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD49399_4, EXP: 5/16/2014; ASPIRIN, CHEW Tablet, 81 mg, NDC 00536329736, Pedi

Code information

ATORVASTATIN CALCIUM, Tablet, 10 mg has the following codes: Pedigree: AD33897_4, EXP: 5/9/2014; Pedigree: AD49582_7, EXP: 5/16/2014; Pedigree: W002774, EXP: 6/6/2014; Pedigree: W003095, EXP: 6/12/2014;

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 167 of 265

ATORVASTATIN CALCIUM, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201777.

D-901-2014

Recall number: D-901-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 811 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD32325_4, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD49582_7, EXP: 5/16/2014.

Code information

ATORVASTATIN CALCIUM, Tablet, 20 mg has the following codes: Pedigree: AD33897_7, EXP: 5/9/2014; Pedigree: AD49582_10, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 168 of 265

ATORVASTATIN CALCIUM, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378212177 .

D-902-2014

Recall number: D-902-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 810 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD33897_4, EXP: 5/9/2014; FINASTERIDE, Tablet, 5 mg, NDC 16714052201, Pedigree: W003031, EXP: 2/28/2014.

Code information

ATORVASTATIN CALCIUM, Tablet, 40 mg has the following codes: Pedigree: AD33897_10, EXP: 5/9/2014; Pedigree: W003096, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 169 of 265

ATORVASTATIN CALCIUM, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378212277.

D-903-2014

Recall number: D-903-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 270 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 11845014882, Pedigree: AD70700_7, EXP: 5/29/2014; TACROLIMUS, Capsule, 0.5 mg, NDC 00781210201, Pedigree: W003169, EXP: 6/13/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD42584_1, EXP: 5/14/2014.

Code information

ATORVASTATIN CALCIUM, Tablet, 80 mg has the following codes: Pedigree: AD73627_1, EXP: 5/30/2014; Pedigree: W003213, EXP: 6/14/2014; Pedigree: AD46300_1, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 170 of 265

MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378225001.

D-904-2014

Recall number: D-904-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as the following drug: PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg, NDC 16714058501, Pedigree: W003761, EXP: 6/26/2014.

Code information

MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes: Pedigree: W003763, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 171 of 265

TEMAZEPAM, Capsule, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378311001.

D-905-2014

Recall number: D-905-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TEMAZEPAM, Capsule, 7.5 mg may have potentially been mislabeled as one of the following drugs: CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium, NDC 00904506260, Pedigree: AD28333_1, EXP: 5/8/2014; VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD49414_7, EXP: 5/17/2014.

Code information

TEMAZEPAM, Capsule, 7.5 mg has the following codes: Pedigree: AD22861_7, EXP: 5/8/2014; Pedigree: AD49418_1, EXP: 5/17/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 172 of 265

CETIRIZINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378363501.

D-906-2014

Recall number: D-906-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CETIRIZINE HCL, Tablet, 5 mg may have potentially been mislabeled as the following drug: LITHIUM CARBONATE ER, Tablet, 300 mg, NDC 00054002125, Pedigree: AD39564_1, EXP: 5/13/2014.

Code information

CETIRIZINE HCL, Tablet, 5 mg has the following codes: Pedigree: AD32757_13, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 173 of 265

ALBUTEROL SULFATE ER, Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378412201.

D-907-2014

Recall number: D-907-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ALBUTEROL SULFATE ER, Tablet, 4 mg may have potentially been mislabeled as one of the following drugs: SIMVASTATIN, Tablet, 20 mg, NDC 16714068303, Pedigree: W003580, EXP: 6/24/2014.

Code information

ALBUTEROL SULFATE ER, Tablet, 4 mg has the following codes: Pedigree: W003578, EXP: 6/24/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 174 of 265

VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.

D-908-2014

Recall number: D-908-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VERAPAMIL HCL ER, Capsule, 240 mg may have potentially been mislabeled as the following drug: FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: W002664, EXP: 6/5/2014.

Code information

VERAPAMIL HCL ER, Capsule, 240 mg has the following codes: Pedigree: W002665, EXP: 6/5/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 175 of 265

FENOFIBRATE, Tablet, 54 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378710077.

D-909-2014

Recall number: D-909-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 270 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as one of the following drugs: LUBIPROSTONE, Capsule, 24 MCG, NDC 64764024060, Pedigree: AD21790_46, EXP: 5/1/2014; aMILoride HCl, Tablet, 5 mg, NDC 64980015101, Pedigree: AD60272_55, EXP: 5/22/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: W002732, EXP: 6/6/2014.

Code information

FENOFIBRATE, Tablet, 54 mg has the following codes: Pedigree: AD21790_52, EXP: 5/1/2014; Pedigree: AD60272_64, EXP: 5/22/2014; Pedigree: W002733, EXP: 6/6/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 176 of 265

FLUVASTATIN, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378802077.

D-910-2014

Recall number: D-910-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: FLUVASTATIN, Capsule, 20 mg may have potentially been mislabeled as the following drug: ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, NDC 00603254421, Pedigree: W002654, EXP: 6/4/2014.

Code information

FLUVASTATIN, Capsule, 20 mg has the following codes: Pedigree: 00378802077, EXP: W002655.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 177 of 265

SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00414200007.

D-911-2014

Recall number: D-911-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 2024 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs: PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD21787_1, EXP: 5/1/2014; HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 76439030910, Pedigree: AD54501_1, EXP: 5/21/2014; VARENICLINE, Tablet, 0.5 mg, NDC 00069046856, Pedigree: W003083, EXP: 6/12/2014; L

Code information

SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg has the following codes: Pedigree: AD21859_1, EXP: 10/31/2013; Pedigree: AD54586_1, EXP: 5/21/2014; Pedigree: W003030, EXP: 6/12/2014; Pedigree: W003866, EXP: 6/27/2014; Pedigree: AD37063_7, EXP: 5/13/2014; Pedigree: W002917, EXP: 6/10/2014; Pedigree: AD54586_4, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 178 of 265

MESALAMINE DR, Capsule, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00430075327.

D-912-2014

Recall number: D-912-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MESALAMINE DR, Capsule, 400 mg may have potentially been mislabeled as the following drug: CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg, NDC 11868000901, Pedigree: AD34928_1, EXP: 5/9/2014.

Code information

MESALAMINE DR, Capsule, 400 mg has the following codes: Pedigree: AD34934_1, EXP: 1/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 179 of 265

THYROID, Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045801.

D-913-2014

Recall number: D-913-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: THYROID, Tablet, 30 mg may have potentially been mislabeled as one of the following drugs: OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg, NDC 11523726503, Pedigree: AD70655_20, EXP: 5/29/2014; NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 37205098769, Pedigree: AD73623_7, EXP: 5/30/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W002697, EXP: 6/5/2014.

Code information

THYROID, Tablet, 30 mg has the following codes: Pedigree: AD65323_1, EXP: 5/29/2014; Pedigree: AD73611_1, EXP: 5/30/2014; Pedigree: W002847, EXP: 6/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 180 of 265

THYROID, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045901.

D-914-2014

Recall number: D-914-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: Unavailable

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: THYROID, Tablet, 60 mg may have potentially been mislabeled as the following drug: THYROID, Tablet, 30 mg, NDC 00456045801, Pedigree: W002847, EXP: 6/7/2014.

Code information

THYROID, Tablet, 60 mg has the following codes: Pedigree: W002848, EXP: 6/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 181 of 265

NEBIVOLOL HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456140530.

D-915-2014

Recall number: D-915-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NEBIVOLOL HCL, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: THYROID, Tablet, 30 mg, NDC 00456045801, Pedigree: AD73611_1, EXP: 5/30/2014; RASAGILINE MESYLATE, Tablet, 0.5 mg, NDC 68546014256, Pedigree: W002929, EXP: 6/10/2014.

Code information

NEBIVOLOL HCL, Tablet, 5 mg has the following codes: Pedigree: AD73611_7, EXP: 5/30/2014; Pedigree: W002930, EXP: 6/10/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 182 of 265

POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00486111101.

D-916-2014

Recall number: D-916-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: POTASSIUM ACID PHOSPHATE, Tablet, 500 mg may have potentially been mislabeled as the following drug: predniSONE, Tablet, 20 mg, NDC 00591544301, Pedigree: AD56879_5, EXP: 5/21/2014.

Code information

POTASSIUM ACID PHOSPHATE, Tablet, 500 mg has the following codes: Pedigree: AD52778_34, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 183 of 265

POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00486111101.

D-917-2014

Recall number: D-917-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: POTASSIUM ACID PHOSPHATE, Tablet, 500 mg may have potentially been mislabeled as the following drug: predniSONE, Tablet, 20 mg, NDC 00591544301, Pedigree: AD56879_5, EXP: 5/21/2014.

Code information

POTASSIUM ACID PHOSPHATE, Tablet, 500 mg has the following codes: Pedigree: AD52778_34, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 184 of 265

SODIUM CHLORIDE, Tablet, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00527111610

D-918-2014

Recall number: D-918-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1000 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1000 mg may have potentially been mislabeled as the following drug: REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: W003925, EXP: 7/1/2014.

Code information

SODIUM CHLORIDE, Tablet, 1000 mg has the following codes: Pedigree: W003925, EXP: 7/1/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 185 of 265

DIGOXIN, Tablet, 125 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527132401.

D-919-2014

Recall number: D-919-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DIGOXIN, Tablet, 125 mcg may have potentially been mislabeled as the following drug: CHOLECALCIFEROL/ CALCIUM/ PHOSPHORUS, Tablet, 120 units/105 mg/81 mg, NDC 64980015001, Pedigree: W002581, EXP: 6/3/2014.

Code information

DIGOXIN, Tablet, 125 mcg has the following codes: Pedigree: AD76675_4, EXP: 6/3/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 186 of 265

LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134101.

D-920-2014

Recall number: D-920-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 600 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg) may have potentially been mislabeled as one of the following drugs: CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD30180_1, EXP: 5/8/2014; carBAMazepine ER, Capsule, 200 mg, NDC 66993040832, Pedigree: AD32764_14, EXP: 5/14/2014; CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 00378022201, Pedigree:

Code information

LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg) has the following codes: Pedigree: AD30140_40, EXP: 5/7/2014; Pedigree: AD46265_40, EXP: 5/15/2014; Pedigree: AD73525_49, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 187 of 265

LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134401.

D-921-2014

Recall number: D-921-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 88 mcg may have potentially been mislabeled as the following drug: guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: W003007, EXP: 6/12/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 88 mcg has the following codes: Pedigree: W003010, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 188 of 265

LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134601.

D-922-2014

Recall number: D-922-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug: RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD60272_19, EXP: 5/22/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes: Pedigree: AD60272_22, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 189 of 265

LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527135001.

D-923-2014

Recall number: D-923-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as one of the following drugs: LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD46265_34, EXP: 5/15/2014; hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W003008, EXP: 6/11/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes: Pedigree: AD46265_37, EXP: 5/15/2014; Pedigree: W003009, EXP: 6/11/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 190 of 265

LEVOTHYROXINE SODIUM, Tablet, 137 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527163801.

D-924-2014

Recall number: D-924-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug: ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014.

Code information

LEVOTHYROXINE SODIUM, Tablet, 137 mcg has the following codes: Pedigree: AD60272_76, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 191 of 265

NICOTINE POLACRILEX, GUM, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536302923.

D-925-2014

Recall number: D-925-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1210 Pieces

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:NICOTINE POLACRILEX, GUM, 2 mg may have potentially been mislabeled as one of the following drugs: FOLIC ACID, Tablet, 1 mg, NDC 65162036110, Pedigree: AD33897_22, EXP: 5/9/2014; QUEtiapine FUMARATE, Tablet, 25 mg, NDC 60505313001, Pedigree: W003099, EXP: 6/13/2014.

Code information

NICOTINE POLACRILEX, GUM, 2 mg has the following codes: Pedigree: AD33897_28, EXP: 2/28/2014; Pedigree: W003100, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 192 of 265

ACETAMINOPHEN, CHEW Tablet, 80 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536323307.

D-926-2014

Recall number: D-926-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 120 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ACETAMINOPHEN, CHEW Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD49423_1, EXP: 5/16/2014; ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003101, EXP: 6/13/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_1, EXP: 5/8/2014; TACROLIMUS,

Code information

ACETAMINOPHEN, CHEW Tablet, 80 mg has the following codes: Pedigree: AD49399_1, EXP: 5/16/2014; Pedigree: W003113, EXP: 6/13/2014; Pedigree: AD30180_7, EXP: 5/8/2014; Pedigree: W003050, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 193 of 265

ASPIRIN, CHEW Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536329736.

D-927-2014

Recall number: D-927-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 4246 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASPIRIN, CHEW Tablet, 81 mg may have potentially been mislabeled as one of the following drugs: OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_4, EXP: 5/8/2014; MODAFINIL, Tablet, 200 mg, NDC 00603466216, Pedigree: W002760, EXP: 6/6/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W003015, EXP: 6/12/2014; VITAMIN B COMPLEX

Code information

ASPIRIN, CHEW Tablet, 81 mg has the following codes: Pedigree: AD33897_1, EXP: 5/9/2014; Pedigree: W002773, EXP: 6/6/2014; Pedigree: W003093, EXP: 6/13/2014; Pedigree: W003459, EXP: 6/20/2014; Pedigree: AD49582_1, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 194 of 265

ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536330501.

D-928-2014

Recall number: D-928-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 900 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as one of the following drugs: PANCRELIPASE DR, Capsule, 0 mg, NDC 42865010302, Pedigree: W003354, EXP: 6/19/2014; acetaZOLAMIDE, Tablet, 250 mg, NDC 51672402301, Pedigree: W003524, EXP: 6/21/2014; METOPROLOL TARTRATE, Tablet, 25 mg, NDC 00378001801, Pedigree: W002535, EXP: 6/3/2014; RIVAROXABAN, Tablet, 20 mg,

Code information

ASPIRIN, Tablet, 325 mg has the following codes: Pedigree: W003355, EXP: 6/19/2014; Pedigree: W003525, EXP: 6/21/2014; Pedigree: W002573, EXP: 6/3/2014; Pedigree: W002624, EXP: 6/4/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 195 of 265

CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536342408.

D-929-2014

Recall number: D-929-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 720 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg may have potentially been mislabeled as one of the following drugs: CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003460, EXP: 6/20/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD60240_1, EXP: 5/22/2014.

Code information

CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg has the following codes: Pedigree: W003461, EXP: 6/20/2014; Pedigree: AD60428_1, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 196 of 265

MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536344308.

D-930-2014

Recall number: D-930-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 180 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg may have potentially been mislabeled as one of the following drugs: MELATONIN, Tablet, 1 mg, NDC 74312002832, Pedigree: W003717, EXP: 6/26/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: AD46257_25, EXP: 5/15/2014; CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: AD73521_7, EXP: 5/30/2014.

Code information

MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg has the following codes: Pedigree: W003714, EXP: 6/26/2014; Pedigree: AD46257_10, EXP: 5/15/2014; Pedigree: AD73521_10, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 197 of 265

CYANOCOBALAMIN, Tablet, 100 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536354201.

D-931-2014

Recall number: D-931-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 99 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CYANOCOBALAMIN, Tablet, 100 mcg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD62834_7, EXP: 5/24/2014.

Code information

CYANOCOBALAMIN, Tablet, 100 mcg has the following codes: Pedigree: AD62840_1, EXP: 5/24/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 198 of 265

CYANOCOBALAMIN, Tablet, 500 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536355101.

D-932-2014

Recall number: D-932-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 700 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:CYANOCOBALAMIN, Tablet, 500 mcg was mislabled as SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: W002859, EXP: 6/7/2014. and may have potentially been mislabeled as one of the following drugs: VITAMIN B COMPLEX W/C, Tablet, 0, NDC 00536730001, Pedigree: AD52993_7, EXP: 5/20/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD30180_22, EXP:

Code information

CYANOCOBALAMIN, Tablet, 500 mcg has the following codes: Pedigree: AD52993_19, EXP: 5/20/2014; Pedigree: AD30180_25, EXP: 5/9/2014; Pedigree: AD37056_10, EXP: 5/10/2014; Pedigree: AD60578_16, EXP: 5/29/2014; Pedigree: W002860, EXP: 6/7/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 199 of 265

CYANOCOBALAMIN, Tablet, 1000 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536355601.

D-933-2014

Recall number: D-933-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 923 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CYANOCOBALAMIN, Tablet, 1000 mcg may have potentially been mislabeled as one of the following drugs: VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD30180_19, EXP: 5/9/2014; COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD37056_4, EXP: 5/10/2014. VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 0, NDC 40985022251, Pedigree: AD7362

Code information

CYANOCOBALAMIN, Tablet, 1000 mcg may have potentially been mislabeled as one of the following drugs: VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD30180_19, EXP: 5/9/2014; COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD37056_4, EXP: 5/10/2014. VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 0, NDC 40985022251, Pedigree: AD73627_26, EXP: 5/30/2014; PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: W003856, EXP: 6/26/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003052, EXP: 6/12/2014; VENLAFAXINE HCL, Tablet, 50 mg, NDC 23155024801, Pedigree: AD65475_22, EXP: 5/28/2014; CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD32757_50, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 200 of 265

DOCUSATE CALCIUM, Capsule, 240 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536375501.

D-934-2014

Recall number: D-934-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1109 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DOCUSATE CALCIUM, Capsule, 240 mg may have potentially been mislabeled as one of the following drugs: diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: AD33897_13, EXP: 5/9/2014; DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD49610_1, EXP: 5/16/2014; diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: W002775, EXP: 6/6/2014; VITAMIN B

Code information

DOCUSATE CALCIUM, Capsule, 240 mg has the following codes: Pedigree: AD33897_16, EXP: 5/9/2014; Pedigree: AD49582_16, EXP: 5/16/2014; Pedigree: W002776, EXP: 6/6/2014; Pedigree: W003821, EXP: 6/27/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 201 of 265

DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536375701.

D-935-2014

Recall number: D-935-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1204 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DOCUSATE SODIUM, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs: PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD25452_10, EXP: 4/30/2014; PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD54498_1, EXP: 5/20/2014; LACTOBACILLUS GG, Capsule, 0, NDC 49100036374, Pedigree: AD65457_16, EXP: 5/24/2014; guaiFENesin ER, Table

Code information

DOCUSATE SODIUM, Capsule, 250 mg has the following codes: Pedigree: AD25452_13, EXP: 5/3/2014; Pedigree: AD54498_4, EXP: 5/20/2014; Pedigree: AD65457_19, EXP: 5/24/2014; Pedigree: W003358, EXP: 6/19/2014; Pedigree: W003558, EXP: 6/24/2014; Pedigree: AD60211_11, EXP: 5/22/2014; Pedigree: W003114, EXP: 6/13/2014; Pedigree: AD37063_4, EXP: 5/13/2014; Pedigree: AD73652_1, EXP: 5/29/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 202 of 265

DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536375710.

D-936-2014

Recall number: D-936-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 16,044 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DOCUSATE SODIUM, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs: SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: W003030, EXP: 6/12/2014; ISOSORBIDE MONONITRATE ER, Tablet, 30 mg, NDC 62175012837, Pedigree: AD21790_64, EXP: 5/1/2014; TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg), NDC 00591533501, Pedigree: AD7

Code information

DOCUSATE SODIUM, Capsule, 250 mg has the following codes: Pedigree: W003054, EXP: 6/12/2014; Pedigree: AD21846_11, EXP: 5/1/2014; Pedigree: W002512, EXP: 6/3/2014; Pedigree: AD76675_1, EXP: 6/3/2014; Pedigree: W002694, EXP: 6/5/2014; Pedigree: AD46257_16, EXP: 5/15/2014; Pedigree: AD60236_1, EXP: 5/22/2014; Pedigree: AD60578_5, EXP: 5/29/2014; Pedigree: AD73521_13, EXP: 5/30/2014; Pedigree: W003242, EXP: 6/17/2014; Pedigree: W003315, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 203 of 265

CHOLECALCIFEROL, Capsule, 2000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536379001.

D-937-2014

Recall number: D-937-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 18,282 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CHOLECALCIFEROL, Capsule, 2000 units may have potentially been mislabeled as one of the following drugs: DOXYCYCLINE HYCLATE, Tablet, 100 mg, NDC 53489012002, Pedigree: AD30993_8, EXP: 5/9/2014; VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD60211_20, EXP: 5/21/2014; lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg), NDC 13668004701, Pedigree: A

Code information

CHOLECALCIFEROL, Capsule, 2000 units has the following codes: Pedigree: AD30028_7, EXP: 5/8/2014; Pedigree: AD60240_4, EXP: 5/22/2014; Pedigree: ADWA00002136, EXP: 5/31/2014; Pedigree: W002666, EXP: 6/5/2014; Pedigree: W003016, EXP: 6/12/2014; Pedigree: W003017, EXP: 6/12/2014; Pedigree: W003712, EXP: 6/26/2014; Pedigree: W003713, EXP: 6/26/2014; Pedigree: W003828, EXP: 6/27/2014; Pedigree: AD21846_4, EXP: 5/1/2014; Pedigree: AD46257_7, EXP: 5/15/2014; Pedigree: AD73521_7, EXP: 5/30/2014; Pedigree: W002691, EXP: 6/5/2014; Pedigree: W003314, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 204 of 265

MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536406001.

D-938-2014

Recall number: D-938-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1603 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg may have potentially been mislabeled as one of the following drugs: sitaGLIPtin PHOSPHATE, Tablet, 50 mg, NDC 00006011231, Pedigree: AD62829_11, EXP: 5/23/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W002652, EXP: 6/5/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: AD22865_7, EXP: 5/2/2014; MULTIVITAMIN/M

Code information

MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg has the following codes: Pedigree: AD62992_8, EXP: /23/2014; Pedigree: W002653, EXP: 6/5/2014; Pedigree: AD22865_10, EXP: 5/2/2014; Pedigree: AD22865_13, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 205 of 265

CALCIUM POLYCARBOPHIL, Tablet, 625 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536430611.

D-939-2014

Recall number: D-939-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCIUM POLYCARBOPHIL, Tablet, 625 mg may have potentially been mislabeled as the following drug: CAFFEINE, Tablet, 100 mg (1/2 of 200 mg), NDC 24385060173, Pedigree: ADWA00002146, EXP: 5/31/2014.

Code information

CALCIUM POLYCARBOPHIL, Tablet, 625 mg has the following codes: Pedigree: AD73592_11, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 206 of 265

PYRIDOXINE HCL, Tablet, 25 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440601.

D-940-2014

Recall number: D-940-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 102 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 25 mg may have potentially been mislabeled as the following drug: TORSEMIDE, Tablet, 10 mg, NDC 50111091601, Pedigree: AD30197_25, EXP: 5/9/2014.

Code information

PYRIDOXINE HCL, Tablet, 25 mg has the following codes: Pedigree: AD30197_28, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 207 of 265

PYRIDOXINE HCL, Tablet, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440801.

D-941-2014

Recall number: D-941-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 695 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 50 mg may have potentially been mislabeled as one of the following drugs: LACTOBACILLUS GG, Capsule, 15 Billion Cells, NDC 49100036374, Pedigree: W003787, EXP: 6/27/2014; LEVOTHYROXINE/ LIOTHYRONINE, Tablet, 19 mcg/4.5 mcg, NDC 42192032901, Pedigree: AD30197_19, EXP: 3/31/2014; CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg, NDC 00

Code information

PYRIDOXINE HCL, Tablet, 50 mg has the following codes: Pedigree: W003824, EXP: 6/27/2014; Pedigree: AD30197_22, EXP: 5/9/2014; Pedigree: AD60428_10, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 208 of 265

PYRIDOXINE HCL, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536440901.

D-942-2014

Recall number: D-942-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 299 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PYRIDOXINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD73627_29, EXP: 5/30/2014; COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W003871, EXP: 6/27/2014; VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 0 mg, NDC 40985022251, Pedigree: AD76686_1, EXP: 5/31/201

Code information

PYRIDOXINE HCL, Tablet, 100 mg has the following codes: Pedigree: AD73627_32, EXP: 5/30/2014; Pedigree: W003872, EXP: 6/27/2014; Pedigree: AD76686_4, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 209 of 265

VITAMIN B COMPLEX, Capsule, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536478701.

D-943-2014

Recall number: D-943-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 399 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VITAMIN B COMPLEX, Capsule, 0 mg may have potentially been mislabeled as the following drug: ACARBOSE, Tablet, 25 mg, NDC 23155014701, Pedigree: AD32757_1, EXP: 5/13/2014.

Code information

VITAMIN B COMPLEX, Capsule, 0 mg has the following codes: Pedigree: AD32757_4, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 210 of 265

NIACIN TR, Tablet, 750 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536703301.

D-944-2014

Recall number: D-944-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN TR, Tablet, 750 mg may have potentially been mislabeled as the following drug: NORTRIPTYLINE HCL, Capsule, 50 mg, NDC 00093081201, Pedigree: AD46414_47, EXP: 5/16/2014.

Code information

NIACIN TR, Tablet, 750 mg has the following codes: Pedigree: AD46414_56, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 211 of 265

NIACIN TR, Tablet, 1000 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536703801.

D-945-2014

Recall number: D-945-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIACIN TR, Tablet, 1000 mg may have potentially been mislabeled as the following drug: NIACIN TR, Tablet, 750 mg, NDC 00536703301, Pedigree: AD46414_56, EXP: 5/16/2014.

Code information

NIACIN TR, Tablet, 1000 mg has the following codes: Pedigree: AD46414_50, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 212 of 265

LACTOBACILLUS ACIDOPHILUS, Tablet, 35 MILLION, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536718101.

D-946-2014

Recall number: D-946-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LACTOBACILLUS ACIDOPHILUS, Tablet, 35 MILLION may have potentially been mislabeled as the following drug: REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: W003924, EXP: 6/28/2014.

Code information

LACTOBACILLUS ACIDOPHILUS, Tablet, 35 MILLION has the following codes: Pedigree: W003865, EXP: 6/27/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 213 of 265

VITAMIN B COMPLEX W/C, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536730001.

D-947-2014

Recall number: D-947-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VITAMIN B COMPLEX W/C, Tablet, 0 mg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD54516_4, EXP: 5/20/2014.

Code information

VITAMIN B COMPLEX W/C, Tablet, 0 mg has the following codes: Pedigree: AD52993_7, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 214 of 265

MULTIVITAMIN/MULTIMINERAL W/IRON, CHEW Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536781601.

D-948-2014

Recall number: D-948-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 102 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MULTIVITAMIN/MULTIMINERAL W/IRON, CHEW Tablet, 0 mg may have potentially been mislabeled as the following drug: CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W003017, EXP: 6/12/2014.

Code information

MULTIVITAMIN/MULTIMINERAL W/IRON, CHEW Tablet, 0 mg has the following codes: Pedigree: W003018, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 215 of 265

ISONIAZID, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555007102.

D-949-2014

Recall number: D-949-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 600 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ISONIAZID, Tablet, 300 mg may have potentially been mislabeled as one of the following drugs: hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W003690, EXP: 6/26/2014; CETIRIZINE HCL, Tablet, 5 mg, NDC 00378363501, Pedigree: AD32757_13, EXP: 5/13/2014; RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: AD32757_47, EXP: 5/13/2014; DULoxetine HCl DR,

Code information

ISONIAZID, Tablet, 300 mg has the following codes: Pedigree: W003691, EXP: 6/26/2014; Pedigree: AD32757_31, EXP: 5/13/2014; Pedigree: AD32757_28, EXP: 5/13/2014; Pedigree: AD60272_70, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 216 of 265

chlordiazePOXIDE HCl, Capsule, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555015902.

D-950-2014

Recall number: D-950-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1,101 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: chlordiazePOXIDE HCl, Capsule, 25 mg may have potentially been mislabeled as one of the following drugs: FLECAINIDE ACETATE, Tablet, 50 mg, NDC 65162064110, Pedigree: AD46414_16, EXP: 5/16/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD49463_1, EXP: 5/16/2014; LACTOBACILLUS GG, Capsule, 0 mg, NDC 49100036374, Pedigree: W003173, EXP: 6/13/2014.

Code information

chlordiazePOXIDE HCl, Capsule, 25 mg has the following codes: Pedigree: AD46333_4, EXP: 5/16/2014; Pedigree: AD49426_1, EXP: 5/16/2014; Pedigree: W003194, EXP: 6/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 217 of 265

hydrOXYzine PAMOATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555032402.

D-951-2014

Recall number: D-951-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 800 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: hydrOXYzine PAMOATE, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs: CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), NDC 00904506260, AD46257_43, EXP: 5/15/2014; guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W002734, EXP: 6/6/2014; guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W003689, EXP: 6/26/20

Code information

hydrOXYzine PAMOATE, Capsule, 100 mg has the following codes: Pedigree: AD46265_28, EXP: 5/15/2014; Pedigree: W002735, EXP: 6/6/2014; Pedigree: W003690, EXP: 6/26/2014; Pedigree: AD21790_61, EXP: 5/1/2014; Pedigree: AD60272_67, EXP: 5/22/2014; Pedigree: W003008, EXP: 6/11/2014; Pedigree: W003332, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 218 of 265

ESTRADIOL, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555089902.

D-952-2014

Recall number: D-952-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ESTRADIOL, Tablet, 0.5 mg may have potentially been mislabeled as the following drug: NICOTINE POLACRILEX, GUM, 2 mg, NDC 00536302923, Pedigree: AD33897_28, EXP: 2/28/2014.

Code information

ESTRADIOL, Tablet, 0.5 mg has the following codes: Pedigree: AD30993_11, EXP: 5/9/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 219 of 265

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574010601.

D-953-2014

Recall number: D-953-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 102 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: W003725, EXP: 6/26/2014.

Code information

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes: Pedigree: W003754, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 220 of 265

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574010603.

D-954-2014

Recall number: D-954-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 63 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs: BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD68010_1, EXP: 5/28/2014; THIORIDAZINE HCL, Tablet, 50 mg, NDC 00378061601, Pedigree: AD73525_28, EXP: 5/30/2014.

Code information

BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes: Pedigree: AD68010_4, EXP: 5/28/2014; Pedigree: AD73525_40, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 221 of 265

CALCIUM ACETATE, Tablet, 667 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00574011302.

D-955-2014

Recall number: D-955-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 401 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CALCIUM ACETATE, Tablet, 667 mg may have potentially been mislabeled as one of the following drugs: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD30028_34, EXP: 5/7/2014; HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg, NDC 00574024701, Pedigree: W003614, EXP: 6/25/2014.

Code information

CALCIUM ACETATE, Tablet, 667 mg has the following codes: Pedigree: AD23098_1, EXP: 5/8/2014; Pedigree: W003637, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 222 of 265

LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 00574022001, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574022001.

D-956-2014

Recall number: D-956-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LIOTHYRONINE SODIUM, Tablet, 5 mcg may have potentially been mislabeled as one of the following drugs: LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC 00574022201, Pedigree: W003152, EXP: 4/30/2014.

Code information

LIOTHYRONINE SODIUM, Tablet, 5 mcg has the following codes: Pedigree: W003153, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 223 of 265

LIOTHYRONINE SODIUM, Tablet, 25 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574022201.

D-957-2014

Recall number: D-957-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LIOTHYRONINE SODIUM, Tablet, 25 mcg may have potentially been mislabeled as one of the following drugs: LEVOTHYROXINE SODIUM, Tablet, 175 mcg, NDC 00378181701, Pedigree: W003151, EXP: 6/13/2014; HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: W003000, EXP: 6/11/2014.

Code information

LIOTHYRONINE SODIUM, Tablet, 25 mcg has the following codes: Pedigree: W003152, EXP: 4/30/2014; Pedigree: W003001, EXP: 4/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 224 of 265

HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574024701.

D-958-2014

Recall number: D-958-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 101 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg may have potentially been mislabeled as the following drug: FLUoxetine HCl, Capsule, 10 mg, NDC 16714035103, Pedigree: W003613, EXP: 6/25/2014.

Code information

HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg has the following codes: Pedigree: W003614, EXP: 6/25/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 225 of 265

HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574025001.

D-959-2014

Recall number: D-959-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 909 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg may have potentially been mislabeled as one of the following drugs: guanFACINE HCl, Tablet, 2 mg, NDC 65162071310, Pedigree: AD21790_13, EXP: 5/1/2014; CYCLOBENZAPRINE HCL, Tablet, 5 mg, NDC 00591325601, Pedigree: AD46265_4, EXP: 5/15/2014; guanFACINE HCl, Tablet, 2 mg, NDC 65162071310, Pedigree: W003678, EXP: 6/25/2014; guanFACIN

Code information

HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg has the following codes: Pedigree: AD21790_19, EXP: 5/1/2014; Pedigree: AD46265_7, EXP: 5/15/2014; Pedigree: W003679, EXP: 6/25/2014; Pedigree: AD60272_16, EXP: 5/22/2014; Pedigree: AD30140_10, EXP: 5/7/2014; Pedigree: W003000, EXP: 6/11/2014; Pedigree: W003326, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 226 of 265

LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591024001.

D-960-2014

Recall number: D-960-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg) may have potentially been mislabeled as the following drug: traMADol HCl, Tablet, 25 mg (1/2 of 50 mg), NDC 57664037708, Pedigree: AD60272_92, EXP: 5/22/2014.

Code information

LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg) has the following codes: Pedigree: AD60243_1, EXP: 5/22/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 227 of 265

LOXAPINE, Capsule, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591036901.

D-961-2014

Recall number: D-961-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: LOXAPINE, Capsule, 5 mg may have potentially been mislabeled as the following drug: SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD46426_1, EXP: 5/15/2014.

Code information

LOXAPINE, Capsule, 5 mg has the following codes: Pedigree: AD46426_7, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 228 of 265

VERAPAMIL HCL, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591040401.

D-962-2014

Recall number: D-962-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 196 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: VERAPAMIL HCL, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W003095, EXP: 6/12/2014; TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: W003352, EXP: 3/31/2014.

Code information

VERAPAMIL HCL, Tablet, 40 mg has the following codes: Pedigree: W003170, EXP: 6/13/2014; Pedigree: W003353, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 229 of 265

ESTROPIPATE, Tablet, 0.75 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591041401.

D-963-2014

Recall number: D-963-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ESTROPIPATE, Tablet, 0.75 mg may have potentially been mislabeled as the following drug: MESALAMINE DR, Capsule, 400 mg, NDC 00430075327, Pedigree: AD34934_1, EXP: 1/31/2014.

Code information

ESTROPIPATE, Tablet, 0.75 mg has the following codes: Pedigree: AD34934_4, EXP: 5/10/2014

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 230 of 265

TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591042401.

D-964-2014

Recall number: D-964-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg may have potentially been mislabeled as the following drug: SEVELAMER HCL, Tablet 800 mg, NDC 58468002101, Pedigree: W002858, EXP: 6/7/2014.

Code information

TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg has the following codes: Pedigree: W002900, EXP: 6/10/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 231 of 265

guanFACINE HCl, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591044401.

D-965-2014

Recall number: D-965-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 500 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: guanFACINE HCl, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: buPROPion HCl ER, Tablet, 200 mg, NDC 47335073886, Pedigree: W002727, EXP: 6/6/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD39588_7, EXP: 5/13/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, NDC 11523726503, Pedigree: W003873, EXP: 6/2

Code information

guanFACINE HCl, Tablet, 1 mg has the following codes: Pedigree: W002728, EXP: 4/30/2014; Pedigree: AD39611_1, EXP: 4/30/2014; Pedigree: W003791, EXP: 6/27/2014; Pedigree: AD73525_13, EXP: 4/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 232 of 265

PROPAFENONE HCL, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591058201.

D-966-2014

Recall number: D-966-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PROPAFENONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug: FOSINOPRIL SODIUM, Tablet, 10 mg, NDC 00185004109, Pedigree: AD54549_7, EXP: 5/20/2014.

Code information

PROPAFENONE HCL, Tablet, 150 mg has the following codes: Pedigree: AD54549_13, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 233 of 265

DICYCLOMINE HCL, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591079501.

D-967-2014

Recall number: D-967-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DICYCLOMINE HCL, Tablet, 20 mg may have potentially been mislabeled as the following drug: RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD76639_1, EXP: 5/31/2014.

Code information

DICYCLOMINE HCL, Tablet, 20 mg has the following codes: Pedigree: AD76639_4, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 234 of 265

DESMOPRESSIN ACETATE, Tablet 0.1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591246401.

D-968-2014

Recall number: D-968-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 98 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: DESMOPRESSIN ACETATE, Tablet 0.1 mg may have potentially been mislabeled as the following drug: LOXAPINE, Capsule, 5 mg, NDC 00591036901, Pedigree: AD46426_7, EXP: 5/15/2014.

Code information

DESMOPRESSIN ACETATE, Tablet 0.1 mg has the following codes: Pedigree: AD46426_16, EXP: 5/15/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 235 of 265

CLINDAMYCIN HCL, Capsule, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591312001.

D-969-2014

Recall number: D-969-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CLINDAMYCIN HCL, Capsule, 300 mg may have potentially been mislabeled as the following drug: MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD68019_7, EXP: 5/28/2014.

Code information

CLINDAMYCIN HCL, Capsule, 300 mg has the following codes: Pedigree: AD67989_1, EXP: 5/28/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 236 of 265

NIFEdipine ER, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591319401.

D-970-2014

Recall number: D-970-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: NIFEdipine ER, Tablet, 60 mg may have potentially been mislabeled as the following drug: NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: W003749, EXP: 6/26/2014.

Code information

NIFEdipine ER, Tablet, 60 mg has the following codes: Pedigree: W003729, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 237 of 265

PIOGLITAZONE, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591320530.

D-971-2014

Recall number: D-971-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 90 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PIOGLITAZONE, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs: LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: AD21846_31, EXP: 5/1/2014; PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD25452_7, EXP: 5/3/2014; ARIPiprazole, Tablet, 15 mg, NDC 59148000913, Pedigree: AD28322_1, EXP: 5/6/2014.

Code information

PIOGLITAZONE, Tablet, 15 mg has the following codes: Pedigree: AD22845_1, EXP: 4/30/2014; Pedigree: AD25452_10, EXP: 4/30/2014; Pedigree: AD28322_4, EXP: 4/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 238 of 265

CYCLOBENZAPRINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591325601.

D-972-2014

Recall number: D-972-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CYCLOBENZAPRINE HCL, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD46257_62, EXP: 5/15/2014; ATENOLOL, Tablet, 12.5 mg (1/2 of 25 mg), NDC 63304062101, Pedigree: AD73525_1, EXP: 5/30/2014.

Code information

CYCLOBENZAPRINE HCL, Tablet, 5 mg has the following codes: Pedigree: AD46265_4, 5/15/2014; Pedigree: AD73525_7, 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 239 of 265

PROGESTERONE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591396401.

D-973-2014

Recall number: D-973-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 99 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:PROGESTERONE, Capsule, 100 mg may have potentially been mislabeled as the following drug: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD73623_10, EXP: 5/30/2014.

Code information

PROGESTERONE, Capsule, 100 mg has the following codes: Pedigree: AD73611_4, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 240 of 265

TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591533501.

D-974-2014

Recall number: D-974-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg) may have potentially been mislabeled as the following drug: PERPHENAZINE, Tablet, 16 mg, NDC 00781104901, Pedigree: AD73525_22, EXP: 5/30/2014.

Code information

TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg) has the following codes: Pedigree: AD73525_34, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 241 of 265

quiNIDine SULFATE, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591543801.

D-975-2014

Recall number: D-975-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:quiNIDine SULFATE, Tablet, 200 mg may have potentially been mislabeled as the following drug: QUINAPRIL, Tablet, 40 mg, NDC 31722027090, Pedigree: AD52778_76, EXP: 5/21/2014.

Code information

quiNIDine SULFATE, Tablet, 200 mg has the following codes: Pedigree: AD52778_79, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 242 of 265

predniSONE, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591544301.

D-976-2014

Recall number: D-976-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 603 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:predniSONE, Tablet, 20 mg may have potentially been mislabeled as the following drug: methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD54587_7, EXP: 5/21/2014.

Code information

predniSONE, Tablet, 20 mg has the following codes: Pedigree: AD56879_5, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 243 of 265

MINOXIDIL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591564201.

D-977-2014

Recall number: D-977-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup:MINOXIDIL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD52778_43, EXP: 5/20/2014.

Code information

MINOXIDIL, Tablet, 2.5 mg has the following codes: Pedigree: AD52778_49, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 244 of 265

MINOCYCLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569401.

D-978-2014

Recall number: D-978-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 50 mg may have potentially been mislabeled as the following drug: MINOXIDIL, Tablet, 2.5 mg, NDC 00591564201, Pedigree: AD52778_49, EXP: 5/20/2014.

Code information

MINOCYCLINE HCL, Capsule, 50 mg has the following codes: Pedigree: AD52778_46, EXP: 5/20/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 245 of 265

MINOCYCLINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569550.

D-979-2014

Recall number: D-979-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 50 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 100 mg may have potentially been mislabeled as the following drug: PROGESTERONE, Capsule, 100 mg, NDC 00591396401, Pedigree: AD73611_4, EXP: 5/30/2014.

Code information

MINOCYCLINE HCL, Capsule, 100 mg has the following codes: Pedigree: AD73611_10, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 246 of 265

ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00597000160.

D-980-2014

Recall number: D-980-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 300 Capsules

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg may have potentially been mislabeled as the following drug: THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree: AD70639_1, EXP: 5/29/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: W003439, EXP: 6/20/2014; ZINC SULFATE, Capsule, 220 mg, NDC 60258013101, Pedigree: W003641, EXP: 6/25/2014.

Code information

ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg has the following codes: Pedigree: AD70639_4, EXP: 7/28/2013; Pedigree: W003468, EXP: 8/19/2013; Pedigree: W003644, EXP: 8/24/2013.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 247 of 265

BISMUTH SUBSALICYLATE, CHEW Tablet, 262 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00603023516.

D-981-2014

Recall number: D-981-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 30 CHEW Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: BISMUTH SUBSALICYLATE, CHEW Tablet, 262 mg may have potentially been mislabeled as the following drug: IRBESARTAN, Tablet, 150 mg, NDC 00093746556, Pedigree: AD42592_7, EXP: 5/14/2014.

Code information

BISMUTH SUBSALICYLATE, CHEW Tablet, 262 mg has the following codes: Pedigree: AD42592_10, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 248 of 265

ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603254421.

D-982-2014

Recall number: D-982-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg may have potentially been mislabeled as the following drug: ASPIRIN, Tablet, 325 mg, NDC 49348000123, Pedigree: W002640, EXP: 6/4/2014.

Code information

ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg has the following codes: Pedigree: W002654, EXP: 6/4/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 249 of 265

GLYCOPYRROLATE, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603318121.

D-983-2014

Recall number: D-983-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1300 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: GLYCOPYRROLATE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: PARICALCITOL, Capsule, 1 mcg, NDC 00074431730, Pedigree: W002667, EXP: 6/5/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000850, Pedigree: W003244, EXP: 6/17/2014; LACTOBACILLUS, Tablet, 0, NDC 64980012950, Pedigree: AD22865_1, EXP: 5/2/2014.

Code information

GLYCOPYRROLATE, Tablet, 2 mg has the following codes: Pedigree: W002650, 6/5/2014; Pedigree: W003252, 6/17/2014; Pedigree: AD22865_4, 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 250 of 265

HYDROCORTISONE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603389919.

D-984-2014

Recall number: D-984-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 250 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: HYDROCORTISONE, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: carBAMazepine ER, Tablet, 200 mg, NDC 51672412401, Pedigree: AD60272_7, EXP: 5/22/2014; guanFACINE HCl, Tablet, 1 mg, NDC 00591044401, Pedigree: W002728, EXP: 4/30/2014; glyBURIDE, Tablet, 1.25 mg, NDC 00093834201, Pedigree: AD21790_10, EXP: 2/28/2014; ACARBOSE, Tablet, 25 mg

Code information

HYDROCORTISONE, Tablet, 5 mg has the following codes: Pedigree: AD60272_13, EXP: 5/22/2014; Pedigree: W002729, EXP: 6/6/2014; Pedigree: AD21790_16, EXP: 5/1/2014; Pedigree: W003060, EXP: 6/12/2014; Pedigree: W003325, EXP: 6/18/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 251 of 265

methylPREDNISolone, Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603459321.

D-985-2014

Recall number: D-985-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 299 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: methylPREDNISolone, Tablet, 4 mg may have potentially been mislabeled as the following drug: OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, NDC 11523726503, Pedigree: AD42584_15, EXP: 5/14/2014.

Code information

methylPREDNISolone, Tablet, 4 mg may have potentially been mislabeled as the following drug: OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, NDC 11523726503, Pedigree: AD42584_15, EXP: 5/14/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 252 of 265

MODAFINIL, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603466216.

D-986-2014

Recall number: D-986-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 60 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: MODAFINIL, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs: OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, NDC 00173078302, Pedigree: W003692, EXP: 6/26/2014.

Code information

MODAFINIL, Tablet, 200 mg has the following codes: Pedigree: W002760, EXP: 6/6/2014; Pedigree: W003779, EXP: 6/26/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 253 of 265

OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00603497521

D-987-2014

Recall number: D-987-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 199 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg) may have potentially been mislabeled as the following drug: PIMOZIDE, Tablet, 1 mg (1/2 of 2 mg), NDC 57844018701, Pedigree: AD73525_61, EXP: 5/30/2014.

Code information

OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg) has the following codes: Pedigree: AD73525_64, EXP: 5/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 254 of 265

OXYBUTYNIN CHLORIDE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603497521.

D-988-2014

Recall number: D-988-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 299 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: OXYBUTYNIN CHLORIDE, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs: FLECAINIDE ACETATE, Tablet, 100 mg, NDC 00054001125, Pedigree: AD56847_4, EXP: 5/21/2014; SODIUM CHLORIDE, Tablet, 1 gm, NDC 00223176001, Pedigree: W003792, EXP: 6/27/2014; VARENICLINE, Tablet, 0.5 mg, NDC 00069046856, Pedigree: AD22616_1, EXP: 5/2/2014.

Code information

OXYBUTYNIN CHLORIDE, Tablet, 5 mg has the following codes: Pedigree: AD52778_61, EXP: 5/20/2014; Pedigree: W003898, EXP: 6/27/2014; Pedigree: AD22616_4, EXP: 5/2/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 255 of 265

PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603506321.

D-989-2014

Recall number: D-989-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 2400 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs: MELATONIN, Tablet, 1 mg, NDC 47469000466, Pedigree: AD46257_19, EXP: 5/15/2014; LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD60272_25, EXP: 5/22/2014; MONTELUKAST SODIUM, CHEW Tablet, 4 mg, NDC 00006071131, Pedigree: AD76639_11, EXP: 5/31/2014.

Code information

PERPHENAZINE, Tablet, 16 mg has the following codes: Pedigree: AD46265_49, EXP: 5/15/2014; Pedigree: AD60272_82, EXP: 5/22/2014; Pedigree: W002612, EXP: 6/4/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 256 of 265

PHENobarbital, Tablet, 64.8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603516721.

D-990-2014

Recall number: D-990-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PHENobarbital, Tablet, 64.8 mg may have potentially been mislabeled as the following drug: PREGABALIN, Capsule, 200 mg, NDC 00071101768, Pedigree: AD73518_4, EXP: 5/31/2014.

Code information

PHENobarbital, Tablet, 64.8 mg has the following codes: Pedigree: AD73518_7, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 257 of 265

PHENobarbital, Tablet, 97.2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603516821.

D-991-2014

Recall number: D-991-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PHENobarbital, Tablet, 97.2 mg may have potentially been mislabeled as the following drug: PHENobarbital, Tablet, 64.8 mg, NDC 00603516721, Pedigree: AD73518_7, EXP: 5/31/2014.

Code information

PHENobarbital, Tablet, 97.2 mg has the following codes: Pedigree: AD73518_10, EXP: 5/31/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 258 of 265

PHENobarbital, Tablet, 97.2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603516832.

D-992-2014

Recall number: D-992-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1000 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PHENobarbital, Tablet, 97.2 mg may have potentially been mislabeled as the following drug: EFAVIRENZ, Capsule, 200 mg, NDC 00056047492, Pedigree: AD46312_31, EXP: 5/16/2014.

Code information

PHENobarbital, Tablet, 97.2 mg has the following codes: Pedigree: AD46339_1, EXP: 5/16/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 259 of 265

PROPRANOLOL HCL, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603548221.

D-993-2014

Recall number: D-993-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PROPRANOLOL HCL, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg), NDC 00591024001, Pedigree: AD60243_1, EXP: 5/22/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: W003068, EXP: 6/12/2014.

Code information

PROPRANOLOL HCL, Tablet, 10 mg has the following codes: Pedigree: AD60264_1, EXP: 5/22/2014; Pedigree: W003032, EXP: 6/12/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 260 of 265

sulfaSALAzine, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603580121.

D-994-2014

Recall number: D-994-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 299 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: sulfaSALAzine, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: FLUCONAZOLE, Tablet, 200 mg, NDC 00172541360, Pedigree: AD65475_16, EXP: 5/28/2014; PHENYTOIN SODIUM ER, Capsule, 30 mg, NDC 00071374066, Pedigree: W003331, EXP: 6/19/2014.

Code information

has the following codes: Pedigree: AD65475_19, EXP: 5/28/2014; Pedigree: W003335, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 261 of 265

PERPHENAZINE, Tablet, 8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00630506221.

D-995-2014

Recall number: D-995-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PERPHENAZINE, Tablet, 8 mg may have potentially been mislabeled as the following drug: NIFEdipine, Capsule, 10 mg, NDC 59762100401, Pedigree: AD52778_55, EXP: 5/20/2014.

Code information

PERPHENAZINE, Tablet, 8 mg has the following codes: Pedigree: AD54605_1, EXP: 4/30/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 262 of 265

CHOLECALCIFEROL, Tablet, 5000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00761017840.

D-996-2014

Recall number: D-996-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 604 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: CHOLECALCIFEROL, Tablet, 5000 units may have potentially been mislabeled as one of the following drugs: LACTOBACILLUS ACIDOPHILUS, Capsule, 0 mg, NDC 54629011101, Pedigree: AD65311_7, EXP: 5/24/2014; QUINAPRIL HCL, Tablet, 20 mg, NDC 68180055809, Pedigree: W003556, EXP: 6/24/2014; POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, NDC 00486111101, Pedigree: AD52778_34, EXP: 5/20/2

Code information

CHOLECALCIFEROL, Tablet, 5000 units has the following codes: Pedigree: AD65457_10, EXP: 5/24/2014; Pedigree: W003557, EXP: 6/24/2014; Pedigree: AD56917_10, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 263 of 265

TRIFLUOPERAZINE HCL, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781103001.

D-997-2014

Recall number: D-997-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: TRIFLUOPERAZINE HCL, Tablet, 1 mg may have potentially been mislabeled as the following drug: TERBUTALINE SULFATE, Tablet, 2.5 mg, NDC 00115261101, Pedigree: AD52778_88, EXP: 5/21/2014.

Code information

TRIFLUOPERAZINE HCL, Tablet, 1 mg has the following codes: Pedigree: AD52778_91, EXP: 5/21/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 264 of 265

PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781104901.

D-998-2014

Recall number: D-998-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 1200 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs: LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD21790_28, EXP: 5/1/2014; LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W002730, EXP: 6/6/2014; RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: W003680, EXP: 6/25/2014; VENLAFAXINE HCL

Code information

PERPHENAZINE, Tablet, 16 mg has the following codes: Pedigree: AD21790_31, EXP: 5/1/2014; Pedigree: W002731, EXP: 6/6/2014; Pedigree: W003682, EXP: 6/25/2014; Pedigree: AD73525_22, EXP: 5/30/2014; Pedigree: W003328, EXP: 6/19/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

drug · product 265 of 265

METHAZOLAMIDE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781107101.

D-999-2014

Recall number: D-999-2014
Initiated: July 02, 2013
Classification: Class II
Status: Terminated
Recalling firm: Aidapak Services, LLC
Quantity: 100 Tablets

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Label Mixup: METHAZOLAMIDE, Tablet, 50 mg may have potentially been mislabeled as the following drug: BUPRENORPHINE HCL SL, Tablet, 2 mg, NDC 00054017613, Pedigree: AD39573_1, EXP: 5/13/2014.

Code information

METHAZOLAMIDE, Tablet, 50 mg has the following codes: Pedigree: AD37072_11, EXP: 5/13/2014.

Distribution pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

Event summary

Source snapshots represented here

Every recalled product in this event

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information

Distribution pattern

Reason for recall

Code information